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H. PYLORI PATHOGENIC FACTORS 
SUMMARY 
From 1994, Helicobacter pylori was classified by WHO (World Health Organization) as a class I 
carcinogen and its infection has been associated to gastroduodenal disease. It colonizes more 
than half of worldwide population, with a prevalent infection rate in developed countries. In 
spite of the majority of infected people are asymptomatic, around 20% develop severe 
pathologies like peptic ulcers and the 1% lymphoma of the mucosa-associated lymphoid tissue 
(MALT) and stomach cancer. This significant epidemiological study both of the unique 
characteristics of H. pylori inspired many scientists, as bacteriologist, gastroenterologists, cancer 
and pharmaceutical scientists to understand physio-pathological aspects of this bacterium, and 
also microbiologist, taxonomist, microbial ecologist and molecular biologist, for a more detailed 
molecular approach.  
H. pylori, a Gram negative, microaerophilic bacteria that colonize human gastric mucosa. It is not 
an acidophilus bacterium and even if the stomach lumen presents inhospitable condition for 
most microbes, it is able to survive for a short period, sufficient to enter in the highly viscous 
mucosa, reach gastric epithelium, and colonize the gastro-enteric tract. H. pylori colonization is 
mediated by a predominant virulence factor, the flagellar motility associated to chemotaxis. To 
avoid its discharge in the intestinal tract by peristalsis, the bacteria establish a persistent 
infection inside the viscous gastric mucus film that covers the gastric epithelium. A nickel 
containing enzyme, the urease, hydrolyzes the urea present in the stomach to ammonia and 
CO2, buffering the pH of the periplasm. The most severe clinical outcomes are always associated 
to cag+ strains. cag-PAI is defined as the “Cytotoxic Associated Genes Pathogenicity Island” and it 
consists of a characteristic chromosome, flanked by transposable elements. Another important 
virulent factor is the vacuolating cytotoxin A, known as VacA, which induces the formation of 
large cytoplasmic vacuoles in gastric cultured cell lines. Moreover the iron and nickel acquisition 
is essential grow factors and a large number of genes are responsible of this mechanism.  
While the development of an efficient vaccine against H. pylori is now the aim of many 
researchers, the search for new specific antibiotics as a new pharmaceutical target is required 
for the complete eradication of H. pylori. 
In this thesis has been investigate the structural and function role of different pathogenic 
proteins involved in the H. pylori colonization of human gastric mucosa. These potential drug 
targets have been cloned, 8 out of 11 were expressed in a heterologous expression system, after 
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purification, 2 of them generate protein crystals and only one was possible to characterize the 
molecular structure. In particular it has been elucidated a possible physiological role of CeuE 
(HP1561), a Class III SPB (Substrate Binding Protein), crystalized with Ni(His)2 complex and it was 
determined its affinity to the complex by an in vitro approach. The H. pylori flagella play a key 
role during infection allowing the bacterium to move through the mucous layer. The H. pylori 
hook scaffolding protein FlgD were cloned, expressed, purified and crystalized. A study of other 
purified pathogenic H. pylori factors belonging to flagellar component apparatus and 
transcriptional factors involved in cellular stress response has been reported. 
 
To obtain these results, different experimental approaches has been used. Bioinformatics 
analysis of target proteins has been performed to predict the best candidates for a 
crystallographic study and for genetic construction design. Molecular cloning in plasmid vectors 
has been performed from PCR amplification. The expression conditions were optimized and 
performed in E. coli, a heterologous system. The solubility of recombinant proteins were 
checked and obtained also with protein refolding methods. Different purification techniques 
were used in order to obtain pure protein. Target characterization was performed due analytical 
gel filtration, UV spectroscopy, DLS (Dynamic Light Scattering) and CD (Circular Dichroism). The 
proteins were concentrated to crystallization trials. The protein crystals obtained were analyzed 
at ESRF synchrotron (Grenoble, France). Functional in vitro approaches were performed using 
fluorescence spectroscopy, SPR (Surface Plasmon Resonance) and Mass spectroscopy.   
 
In the second chapter is described the three dimensional structure of a H. pylori  pathogenic 
protein crystalized in presence with its possible physiological substrate. HP1561 (CeuE) is a H. 
pylori protein predicted to be an ABC transporter component, periplasmic iron-bind transporter. 
Recently it was published that CeuE and fecDE genes of H. mustelae encode for a nickel and 
cobalt acquisition system. In Gram-negative bacteria, nickel uptake is guaranteed by multiple 
and complex systems that operate at the membrane and periplasmic level. H. pylori employs 
other yet uncharacterized systems to import the nickel required for the maturation of key 
enzymes, such as urease and hydrogenase. To understand this contradiction of the data about 
Ni2+ acquisition system in H. pylori CeuE was cloned, expressed, purified, crystallized and its 
structure determined. Identity between the sequences of the two Helicobacter is 44%. The two 
Histidine residues (H103 and H197), potentially involved in Siderophores/Ni2+ binding 
coordination in H. pylori CeuE, are partially conserved. The His corresponding to H. pylori 
position 103 is conserved, whilst His197 is replaced by a Leucine. In order to check, if this 
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substitution influence the binding of siderophores/Ni2+, the mutant of H. pylori CeuE H197L was 
than produced and purified. The crystal structure of H. pylori CeuE has been determined at 
1.65Å resolution using the SAD method, in Apo-form and in complex with Ni(His)2. It comprises 
two structurally similar globular domains, each consisting of a central five-stranded β-sheet 
surrounded by α-helices, an arrangement commonly classified as a Rossmann-like fold. 
Structurally, H. pylori CeuE belongs to the class III periplasmic substrate-binding protein. 
Crystallographic data, fluorescence binding assays and SPR analysis allow to exclude a role of the 
protein in the transport of VitB12, heme, enterobactin and isolated Ni2+ ions. On the contrary, 
the crystal structure of the protein/Ni(L-His)2 complex and dissociation constant obtained by SPR 
technique suggests that H. pylori CeuE binds and transport nickel in vivo thanks to the formation 
of a Ni2+/histidine complex or to some ligand that mimics it.  
In the third chapter is presented the study of FlgD, a flagellar component involved in the 
formation the extracellular complex, the flagellar hook. The motility of H. pylori is considered a 
colonization factor, due the fact that less motile strains are less able to colonize or survive in the 
host than full motile strains. In the flagellum machinery are involved more than 50 genomic 
genes for regulation and assembly. The three major components are the filament, the hook and 
the basal body. FlgD is not present when the flagellum is completed, but plays a key role during 
the assembly. Therefore, it has been classified as the hook-scaffolding protein, considering it 
also as the hook capping protein, interacting with FlgL and FlgK and the basal body rod – 
modification protein. In H. pylori G27 strain FlgD correspond to the gene hp0858 that was 
amplified from purified genomic DNA and cloned in an expression plasmid vector. The protein 
was produced in E. coli BL21 in reach medium ad it resulted to a soluble protein. DLS and 
analytical gel filtration confirm the oligomeric state of FlgD that resulted to be a tetramer in 
solution. The protein was concentrated to 30g/l and crystalized after a couple of month of 
incubation. The crystals had diffracted at 2.7Å of maximum resolution. For molecular 
replacement approach was used homology modeling. Different molecular models were built to 
fit experimental diffraction data. The secondary structure of the generated models was fitted 
with experimental CD spectra, where FlgD resulted to have around 12% of helices and 45% of β-
sheets (190-260nm). Crystallographic statistics do not properly converged to a positive 
molecular refinement with the tested models. To solve FlgD structure are necessary crystals of 
recombinant Selenomethionine FlgD that was expressed, purified and crystalized.      
In the fourth chapter are reported H. pylori pathogenic proteins that had been characterized. 
These proteins could be divided in two groups, the first one of flagellar proteins and the second 
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of cellular stress response factors, in collaboration with Professor V. Scarlato of the department 
of Biology of Bologna University.  
FliN is a cytosolic protein, localized in the C ring of the flagellar basal body. It interacts with the 
other two components FliM and FliG. Missense or mutation of fliN had been associated to non-
motile strains. It has been reported that regulates the clockwise/counterclockwise switching of 
flagella. H. pylori FliN was cloned, expressed and purified from the inclusion body after refolding. 
Oligomerization after refolding was tested by DLS and analytical gel filtration. The protein 
resulted to be poly-disperse in solution and no protein crystals have been obtained.  
FliD is the filament capping protein and it was observed that interact with FliT that is not only a 
flagellar type III substrate specific export chaperone but also inhibits the expression of fliD 
thought its specific interaction with the master regulator FlhD4C2 complex. In order to analyze 
possible structure of the co-crystalized FliD-FliT, it was plan to co-express these proteins. Both 
were cloned with a different affinity purification system, but only FliT was possible to express 
and purify from inclusion bodies. The CD spectra presented a strong β-sheet component in the 
secondary structure. DLS and analytical gel filtration revealed that this protein is poly-disperse in 
solution and no protein crystals were be obtained.    
FlgN is a type III secretion chaperone and it has been reported to interact with the two hook 
junction protein FlgK and FlgL preventing the protein proteolysis when the flagellum is not 
assembled. These proteins have been cloned in different type of plasmid vectors for a co-
expression experiment, but only FlgN was properly expressed in E. coli. Recombinant FlgN was 
purified by Ni-IMAC and resulted to be soluble in solution. The protein was characterized by 
analytical gel filtration, DLS and CD. The protein resulted to be a monomer in solution with a 
30% of not defined secondary structure (190-260nm). FlgN was concentrated and different 
crystallization conditions were tested.   
In the latter group there are three proteins related to Heat shock response, produced when 
bacteria encounter stress such as the elevated temperatures, ethanol, H2O2 and acid. It was 
demonstrated that H. pylori Hsps play an important role during the host infection. HrcA and 
HspR are negative repressor of groESL and dnaK machinery. HrcA activity depends by the 
presence of HspR, because it is demonstrated that HrcA is not able to bind DNA in absence of 
HspR. These two proteins were expressed in E. coli and purified by Ni-IMAC affinity. During the 
concentration step, these proteins present a solubility limit influenced by the concentration. 
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Mutagenesis of a Cys in HspR and detergent solubility screening with HrcA has been performed, 
but no suitable protein for crystallization trials has been obtained.   
Hp1026 is a gene present in the same operon of HspR (hp1025). The function of this gene has 
not been reported. From sequence homology was possible to identify a helicase domain and 
ATP-binding domain. This protein, ORF, has been expressed in E. coli and purified by Ni-IMAC 
affinity. Analytical gel filtration and CD has been performed to characterize this protein. The 
protein was a dimer in solution with a 35% of α-helices component. Crystallization trials have 
been performed at different protein concentrations and also in presence of its possible cofactor, 
ATPγS. No crystals have been obtained in tested condition. 
  
Appendix:  
Structural and functional study on a human protease S1P/ SKI1  
The study of human S1P/SKI1 protease was performed in collaboration with Professor S. Kunz of 
the Institute of Microbiology, University Hospital Center and university of Lausanne, Switzerland. 
S1P/SKI-1 is a serine protease that belongs to the mammalian family of Proprotein Convertases 
(PC). The aim of this family member is to mediate the activation of different important 
substrates for cell live. Among these proteases, S1P has been shown to have unique substrate 
specificity, preferring cleavage after non-basic amino acids. Known S1P cellular targets are 
SREBP-2, involved in the biosynthesis and uptake of lipids and cholesterol, BDNF, ATF-6 and the 
surface glycoprotein of viruses belonging to the family of Arenaviridae. S1P is 118 kDa multi-
domain protein; two regions of S1P have been investigated, the "Prodomain", involved in the 
regulation of S1P catalytic activity, and the so called "catalytic domain", which include the 
residues responsible for the cleavage reaction itself. Moreover it was analyzed an inactive 
mutant of cS1P: H249A. Also for ProD was chosen one constructs (ProD_AB and ProD_AC) 
involved in the affinity of the protease substrate. Hence, the sequences corresponding to the 
domains were synthesized as optimized genes for the expression in E. coli and sub-cloned in 
expression plasmids in order to obtain C-term His-tagged fusion proteins. These constructs have 
been expressed in E. coli, purified by Ni-IMAC and positive fractions have been collected and 
concentrated in order to perform crystallization trials. Unfortunately no protein crystals have 
been obtained in tested condition. To elucidate the role of a mutated variant of the cleavage site 
“C” of Pro Domain, it was performed a mass spectrometry analysis. Secreted S1P/SKI1 mutant C 
was purified from culture medium of HEK293 cell line was isolated by IMAC-Co. The sample, 
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loaded in RP-HPLC, was denatured in 6 M Guanidine-HCl. The chromatographic fractions 
corresponding to the major HPLC peaks were dried out in a speed-vac concentrator and directly 
injected in the ESI source. Mass measurements were performed with a quadrupole-TOF 
spectrometer. Analysis of mass spectra, compared with wild-type form of S1P, allows generating 
a preliminary Pro Domain auto-processing profile. 
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SOMMARIO 
Dal 1994 il batterio Helicobacter pylori è stato classificato come organismo cancerogeneno di 
prima classe e la sua infezione è associata a patologie gastroduodenali. Più di metà della 
popolazione mondiale ne è infettata con una maggiore prevalenza nei paesi sviluppati. 
Nonostante la maggior parte dei casi le infezioni sono asintomatiche, il 20% sviluppa gravi 
patologie come ulcere peptiche e nell’1% dei casi genera linfomi e gastro carcinomi. L’incidenza 
e le caratteristiche di questo batterio hanno ispirato batteriologi, gastroenterologi, oncologi e 
farmacologi per indagare gli aspetti fisiopatologici legati all’infezione, così come microbiologi, 
ecologi, biologi molecolari hanno cercato i fattori di virulenza coinvolti in nell’infezione.    
H. pylori è un batterio microaerofilico Gram negativo che colonizza la mucosa gastrica. Non è un 
batterio acidofilo, anche se è in grado di sopravvivere nel lume dello stomaco per un breve 
periodo necessario per raggiungere le cellule epiteliali spostandosi attraverso la mucosa gastrica. 
La colonizzazione è mediata da fattori di virulenza predominanti come la motilità flagellare 
associata alla chemiotassi. Per evitare che sia espulso dal tratto intestinale dalla peristalsi, il 
batterio H. pylori stabilisce un’infezione cronica. L’ureasi, che è un enzima nickel dipendente, che 
idrolizza l’urea presente in ammoniaca e CO2 tamponando il pH acido dello stomaco. I casi più 
gravi sono associati ai ceppi che esprimono l’isola di patogenicità cag-PAI, che consiste in un 
cromosoma delimitato da elementi trasponibili. Un altro importante fattore di virulenza è la 
tossina vacuolizzante VacA, che induce la formazione di vacuoli citoplasmatici. Anche il 
meccanismo di acquisizione di ferro e nickel è fondamentale per la colonizzazione batterica e 
dunque finemente regolata da un gran numero di geni. 
Lo sviluppo di un vaccino e nuovi antibiotici nutrono una costante ricerca di nuovi possibili 
bersagli farmacologici, necessari per completa ed efficiente eradicazione del batterio H. pylori.   
In questa tesi sono stati analizzati il ruolo e la struttura di alcune proteine patogenetiche del H. 
pylori. Questi potenziali target farmacologici sono stati clonati, otto su undici sono stati espressi 
in un sistema eterologo, due proteine di quelle purificate hanno generato cristalli e di una sola 
ne è stata definita la struttura molecolare. In particolare è stato definito un possibile ruolo della 
proteina CeuE (HP1561), appartenete alla famiglia delle proteine che legano un substrato, 
cristallizzata in presenza del complesso Ni(His)2 e definita l’affinità con lo stesso in vitro. 
Del flagello, che svolge un ruolo chiave durante l’infezione, ne è stata studiata la proteina 
coinvolta nella formazione dell’uncino FlgD che è stata clonata, espressa, purificata e 
cristallizzata. 
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Inoltre è stato riportato anche uno studio di altri fattori del flagello e di alcune proteine 
coinvolte nella risposta allo stress cellulare. 
Per ottenere tali risultati sono stati utilizzati approcci differenti. Per individuare le migliori 
proteine candidate per uno studio cristallografico e progettare costrutti funzionali sono state 
effettuate predizioni bioinformatiche. Gli amplificati di PCR sono stati clonati in vettori 
plasmidici. Le condizioni di espressione sono state ottimizzate e fatte in E. coli, un sistema di 
espressione eterologo. La solubilità delle proteine ricombinanti è stata analizzata e ottenuta 
anche mediante refolding. Sono stati usati diversi sistemi di purificazione per ottenere un buon 
grado di purezza. Per la caratterizzazione proteica sono state usate come tecniche la gel 
filtrazione analitica, spettroscopia UV, DLS (Dynamic Light Scattering) e dicroismo circolare. Le 
proteine sono state concentrate e sottoposte a esperimenti di cristallizzazione. I cristalli sono 
stati analizzati al sincrotrone ESRF (Grenoble, France). Spettroscopia di fluorescenza, SPR 
(surface plasmon resonance) e spettroscopia di massa sono le tecniche utilizzate per la 
caratterizzazione In Vitro. 
Nel secondo capitolo viene decritta la struttura tridimensionale di una proteina patogenetica di 
H. pylori, cristallizzata in presenza del suo possibile substrato fisiologico. HP1561 (CeuE) è una 
proteina di H. pylori annotata come componente periplasmatico di un trasportatore  ABC che 
lega e trasporta il ferro. Recentemente è stato pubblicato chele ceuE e fecDE di H. mustelae 
codificano per proteine coinvolte nel acquisizione del nickel e cobalto. Nei Gram negativi, 
l’acquisizione del nickel è garantita da sistemi di proteine che operano a livello di membrana e 
periplasmatico. Per l’acquisizione del nickel, l’ H. pylori integra diversi sistemi non ancora 
caratterizzati, necessari per la maturazione di enzimi chiave come l’ureasi e l’idrogenasi. Per 
chiarire tale contraddizione nel sistema di acquisizione del nickel nell’H. pylori, CeuE è stata 
clonata, espressa, purificata, cristallizzata e la sua struttura è stata risolta. L’identità di sequenza 
tra i due Helicobacter (pylori e mustelae) è del 44%. Le due Istidine (H103 e H197), 
potenzialmente coinvolte nel legame di coordinazione del sistema sideroforo/Ni2+ nel H. pylori 
CeuE, risultano essere parzialmente conservate. L’His corrispondente alla His103 di H. pylori è 
conservata, mentre His197 è sostituita da una Leucina. Al fine d’identificare se tale mutazione 
possa influenzare il legame sideroforo/Ni2+, è stato prodotto e purificato il mutante H. pylori 
CeuE H197L. La struttura molecolare di H. pylori CeuE è stata determinata con una risoluzione di 
1.65 Å mediante metodo SAD, sia nella forma apo, che in complesso col Ni(His)2. Essa è costituita 
da due domini globulari simili, ognuno costituito da cinque foglietti-β circondati da α-eliche, 
comunemente classificato come Rossman fold. Strutturalmente H. pylori CeuE appartiene alla 
Classe III della famiglia di proteine che legano un substrato specifico (SBPs). Dati cristallografici, 
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saggi di fluorescenza e analisi all’SPR ci permettono di escludere il coinvolgimento della proteina 
nel trasporto della VitB12, eme, entrobactina, e ioni Ni2+ isolati. Al contrario la struttura della 
proteina/complesso Ni(His)2 e le costanti di dissociazione ottenute mediante SPR suggeriscono 
che H. pylori CeuE lega e trasporta il nickel in vivo mediante il complesso Ni2+/His o altro ligando 
che lo mima. 
Nel terzo capitolo viene presentato lo studio su FlgD, una proteina flagellare fondamentale nella 
formazione di un complesso extracellulare, l’uncino del flagello. La motilità dell’H. pylori è 
considerata un fattore di colonizzazione, attraverso il quale ceppi meno motili hanno minori 
possibilità di colonizzare e sopravvivere nell’ospite di ceppi più motili. Per la formazione del 
flagello sono coinvolti più di 50 geni per la regolazione e l’assemblaggio delle varie componenti.  
Le tre componenti principali sono il filamento, l’uncino e il corpo basale. FlgD non è presente 
quando il flagello è maturo, ma ha un ruolo chiave durante l’assemblaggio. Perciò, è stato 
classificato come proteina necessaria per l’impalcatura dell’uncino (hook scaffolding protein), 
considerata anche proteina di testa dell’uncino (capping protein) in quanto interagisce con FlgL, 
FlgK e le proteine del corpo basale. Nel ceppo H. pylori G27, FlgD corrisponde al gene hp0858 
che è stato amplificato dal DNA genomico purificato e clonato in un vettore plasmidico. La 
proteina è stata prodotta in E. coli BL21 e la proteina è risultata essere solubile. Gel filtrazione 
analitica e misure al DLS confermano il suo stato di oligomerizzazione, che risulta essere un 
tetramero in soluzione. La proteina è stata concentrata fino a 30 g/l e cristallizzata dopo un paio 
di mesi d’incubazione. I cristalli hanno diffratto a una risoluzione massima di 2.7 Å. Per la 
sostituzione molecolare è stata usata la tecnica del homology modelling. Sono stati costruiti 
diversi modelli molecolari per fittare i dati sperimentali. La struttura secondaria dei modelli 
generati è stata comparata con gli spettri di dicroismo circolare, dove FlgD è risultata essere 
composta da un 12% di eliche e complessivamente da un 45% di foglietti beta (190-260nm). Le 
statistiche cristallografiche non hanno dato convergenza positiva negli esperimenti di 
sostituzione molecolare con i modelli testati. Per risolvere la struttura di FlgD sono necessari 
cristalli di FlgD derivatizzata con Selenometionine, che è stata espressa, purificata e cristallizzata. 
Nel quarto capitolo sono riportate le proteine patogenetiche di H. pylori che sono state 
caratterizzate in questa tesi. Queste proteine possono essere divise in due gruppi, il primo delle 
proteine flagellarli ed il secondo delle proteine coinvolte nella risposta allo stress cellulare in 
collaborazione con il Prof. V. Scarlato del dipartimento di Biologia dell’università di Bologna. 
FliN è una proteina citosolica localizzata nell’anello C del corpo basale del flagello ed interagisce 
con altri due componenti FliM e FliG. Mutazioni missenso di fliN sono state associate a ceppi 
non-motili ed è stato riportato che regola la rotazione oraria/antioraria del flagello. H. pylori FliN 
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è stata clonata, espresso e purificata dai corpi d’inclusione dopo refolding. Lo grado di 
oligomerizzazione è stato analizzato mediante DLS e gel filtrazione analitica. La proteina è 
risultata essere polidispersa i soluzione e non sono stati ottenuti cristalli di proteina. 
FliD è la proteina “capping” del filamento cellulare ed è stato osservato che interagisce con FliT, 
che non è solo un chaperon substrato specifico del sistema III di esporto flagellare, ma inibisce 
anche l’espressione di fliD attraverso l’interazione con il complesso FlhD4C2. Al fine di analizzare 
la struttura del complesso FliD-FliT, è stata pianificata la co-espressione di queste proteine. 
Entrambe sono state clonate con un sistema di purificazione differente, ma solo la purificazione 
di FliT è stata possibile dai corpi d’inclusione. Lo spettro di dicroismo circolare ha rivelato una 
forte componente di foglietti-β nella struttura secondaria. Secondo le misure di DLS e gel 
filtrazione analitica FliT è polidispersa in soluzione e perciò non stati ottenuti cristalli della stessa. 
FlgN è una proteina del sistema secrezione tipo III ed è stato osservato che interagisce in 
maniera specifica con le proteine di giunzione dell’uncino con il filamento FlgK ed FlgL, 
prevenendone la proteolizzazione prima della maturazione del flagello. Queste proteine sono 
state clonate in differenti tipi di vettori plasmidici, ma solo FlgN è stata efficacemente espressa 
in E. coli. FlgN ricombinante è stata purificata mediante Ni-IMAC è risultata essere solubile. La 
proteina è stata caratterizzata con gel filtrazione analitica, DLS e CD. La proteina è un monomero 
in soluzione con un 30% di struttura secondaria non definita (190-260 nm). FlgN è stata 
concentrata e sottoposta a test di cristallizzazione. 
Nell’ultimo gruppo ci sono tre proteine HSPs (Heat Shock Response), prodotte dal batterio 
quando incontra stress come elevate temperature, etanolo, H2O2 e acidi. E’ stato accurato che le 
HSPs di H. pylori svolgono un ruolo importante durante l’infezione dell’ospite. HrcA e HspR 
reprimono la trascrizione di groESL e dnaK. L’attività di HrcA è influenzata dalla presenza di 
HspR, in quanto è stato dimostrato che HrcA non è in grado di legare il DNA in assenza di HspR. 
Queste due proteine sono state espresse in E. coli e purificate con Ni-IMAC. Durante le fasi di 
concentrazione hanno mostrato un limite di solubilità. Mutagenesi mirata sul costrutto di HspR e 
screening di detergenti su HrcA sono hanno migliorato il sistema, senza però riuscire ad ottenere 
una condizione ottimale per la formazione di cristalli di proteina. 
HP1026 (ORF) è un gene presente nello stesso operone di HspR (hp1025), ma con funzione non 
nota. Dall’analisi della sequenza è stato identificato un dominio con attività elicasica ed un 
dominio legante l’ATP. La proteina è stata espressa in E. coli  e purificata con Ni-IMAC. Per la 
caratterizzazione sono state effettuate gel filtrazione analitica e dicroismo circolare. La proteina 
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risulta essere un dimero in soluzione con un 35% di α-elica. I test di cristallizzazione son stati 
effettuati scrinando diverse concentrazioni e anche in presenza del possibile cofattore, ATPγS in 
forma non idrolizzabile. Nessun cristallo è stato ottenuto dalle condizioni testate.                 
Appendice:  
Studio strutturale e funzionale della proteasi umana S1P/SKI1 
Lo studio di questa proteasi umana è stato effettuato in collaborazione con il Prof. S. Kunz 
dell’Istituto di Microbiologia, del Centro Universitario Ospedaliero e dall’ Univ. Di Lausanne, 
Svizzera. S1P/SKI1 è una serina proteasi della famiglia delle Proprotein Convertasi (PCs). Lo 
scopo di membri di questa famiglia è quello di mediare l’attivazione di diversi importanti 
substrati per la vita cellulare. Tra queste proteasi, S1P presenta una specificità di substrato, con 
un sito di taglio dopo un residuo non basico. Tra i target cellulari di S1P sono stati identificati 
SREBP-2, coinvolto nella biosintesi dei lipidi e del colesterolo, BDNF, ATF-6 e glicoproteine 
superficiali di virus appartenenti alla famiglia delle Arenaviridae. S1P pesa 118kDa ed è una 
proteina multidominio; quindi 2 regioni di S1P sono state studiate, il “Prodomain” (ProD) che 
regola l’attività catalitica, ed il “cathalytic domain” (cS1P) che include i residui responsabili per la 
reazione proteasica. Inoltre è stato analizzato un mutante inattivo (cS1P_H249A) e due costrutti 
per il dominio di regolazione (ProD_AB e ProD_AC). Le sequenze nucleotidiche dei corrispettivi 
costrutti sono state sintetizzate come geni ottimizzati per l’espressione in E. coli  e subclonati in 
vettori plasmidici per l’espressione ottenendo proteine in fusione con una coda di 6-His. Questi 
costrutti sono stati espressi in E. coli, purificati con Ni-IMAC e le frazioni positive sono state 
raccolte e concentrate per test di cristallizzazione. Sfortunatamente non sono stati ottenuti 
cristalli di proteina nelle condizioni testate.  
Per chiarire il ruolo di una variante mutata nel sito di taglio “C” del dominio di regolazione è 
stata effettuata una analisi di spettrometria di massa. La proteina secreta S1P mut C 
(sS1P_MutC, 116kDa) è stata purificata dal medium di coltura di una linea di HEK293 trasfettate 
e isolata con Co-IMAC. Il campione è stato denaturato in Guanidinio 6M e caricato in HPLC. Le 
frazioni corrispondenti ai picchi predominanti sono stati essiccati ed iniettati in spettrometro di 
massa (ESI-TOF). L’analisi delle masse, confrontate con la forma nativa (sS1P_WT) ha permesso 
di generare un profilo preliminare del pattern di processamento del dominio di regolazione 
(ProD)     
with a quadrupole-TOF spectrometer. Analysis of mass spectra, compared with wild-type form of 
S1P, allows generating a Pro Domain auto-processing profile. 
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Chapter 1 
Helicobacter pylori 
General aspects 
Helicobacter pylori is a non-spore forming gram-negative bacterium that colonizes the human 
gastric mucosa of more than half of the world's population (Rothenbacher and Brenner, 2003). 
The presence of microbes in human stomach was firstly described by Bizzozero in the XIX 
century, but only in 1983 Warren and Marshall isolated and characterized H. pylori (Marshall and 
Warren, 1984; Nobel Prize, 2005).  
The interest of the scientific community spread when Barry 
Marshall demonstrated that H. pylori provokes gastritis, drinking a 
suspension of H. pylori during a congress.  
In the scientific literature in the year 2000 more article have been 
published on Helicobacter than on Salmonella or Bacillus, just 
behind Escherichia coli, the most cited bacteria, demonstrating 
how biological research has focused on this field. 
The organism isolated by Warren and Marshall was initially 
classified as Campylobacter pylori for its curved morphology. It is characterized by its ability to 
grow under microaerophilic condition, and by G + C content of 34% (Syst. Bacteriol. 
1985;35:223–225). 16S rRNA sequence analysis revealed its distance from Campylobacter genus 
(Romaniuk P.J., 1987), so it was renamed as Helicobacter pylori (Goodwin C.S., 1989). 
Most of the strains of H. pylori are clinically asymptomatic, but some are pathogenic and they 
can induce gastritis or more sever diseases: 10% of the infected subjects may present peptic 
ulcer and atrophic gastritis. In 1994, the World Health Organization classified it as the first 
bacterial class 1 carcinogen, since 1% of infected individuals may develop gastric 
adenocarcinoma and lymphoma of mucosa-associated lymphoid tissue (MALT) (Blaser, 1998; 
Peek, 2002, Suerbaum, 2002). 
Animal models of infection, such as H. felis and H. mustelae, have been very useful to 
characterized H. pylori virulence factors, together with H. pylori Sydney strain (SS1), which 
present a reproducible mice infection, very useful for the development of new vaccines. Further 
gastric Helicobacter species have been found in humans and animals, particularly in non-human 
primates and domesticated mammals; in particular, enterohepatic Helicobacter, that was for the 
first time isolated by Philips and Lee in 1983 (Robertson B.R., 1987). 
The small genome size of the bacterium, 1,7 Mb, reveals a profile of an organisms that was fine 
Fig. 1.1 Helicobacter pylori 
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tuned for its niche of gastric mucosa: it is an example of co-evolution with the host system, 
compared to the larger E. coli genome, that conserves many regulatory features leaking in H. 
pylori genome. 
 
1.2 Transmission 
H. pylori infection is ubiquitous worldwide, with significant differences in the prevalence of 
infection within and between countries (Goh K. L., 1997; Malaty H. M., 1992). The studies on the 
transmission of H. pylori suggest a human-to-human oral-oral and fecal-oral route (Blaser, 1998), 
but do not exclude common environmental sources, in particular water (Klein P., 1991) and 
animals (Morris A., 1986). The acquisition of H. pylori happens mainly during childhood (Bardhan 
N., 1993) and the prevalence of infection is higher in developing countries (Mitchell H.M., 1992). 
Some studies suggest, from the geographic subdivision of Helicobacter strains, that the 
bacterium has accompanied humans for ten thousands of year during migrations (Kersulyte, 
2000). This could be the reason why H. pylori is a very common human pathogen. It has used 
humans as carrier, possibly providing them with benefits for surviving during long period of 
human history (Suerbaum, 2002). 
The association of H. pylori to different severe pathologies such as peptic ulcer, gastric cancer, 
and B-cell MALT lymphoma requires a quick development of molecular strategies to prevent the 
spread of the bacterium and of antibiotic resistant strain formation. 
 
Genetic variability of H. pylori 
H. pylori genome consists of a circular chromosome, sequenced in 1997 using a random shotgun 
approach. The first strain sequenced was the 26695 strain, which size is 16,667,867 base pair, 
with 39% of G + C content and 1,590 predicted coding sequence (Tomb, 1997). The sequence of 
other strains revealed extensive genetic heterogeneity, possibly caused by the selective pressure 
that had operate on this microorganism together to its specific capability for diversification by 
mutation and recombination. It has been shown that different strains could colonize the same 
individual and thereby the primitive fingerprinting of the host changes during chronic 
colonization (Suerbaum, 2007). The polymorphisms of H. pylori are caused by cumulative events 
of chromosome rearrangements, such as point mutations, recombination, insertions and 
deletions. This adaptation process is reflected on three major group of bacterial cluster genes: i) 
genes involved in the biosynthesis of the DNA machinery uptake, repair and recombination; ii) 
genes that favor bacteria-bacteria interaction and genetic exchange and iii) genes that regulate 
the host interaction. A particular group of polymorphism of DNA, contingent to 5’ of some 
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genes, involves short tandem repeats, which are the responsible for this type of recombination 
improving the heterogeneity among H. pylori strains. This type of slippage provokes the shifting 
in- and out- of frame during the transcription, presenting antigenic variation of the same protein 
(Saunders, 1998). This mechanism is used by bacteria to improve adaptation to changes of the 
host inhospitable living conditions. H. pylori uses its genetic plasticity for persistent infection, 
even if the immune response generated by the host is not sufficient to its eradication, and 
therefore the gastritis pathogenesis of H. pylori is still poorly understood (Suerbaum, 2007). The 
recombination among different strains, correlated to the colonization of different macro-niches 
of human stomach, increase H. pylori fitness, and explain the levels of complexity found in its 
sub-population (Kang, Blaser, 2006). 
 
Acid resistance e virulence aspects 
Helicobacter pylori is not a acidophilus bacterium and even if the stomach lumen presents 
inhospitable condition for most microbes, it is able to survive for a short period, sufficient to 
enter in the highly viscous mucosa, reach gastric epithelium, and colonize the gastroenteric tract 
(Suerbaum, 1999). To complete this sequence of events, it activates a gene cluster (ureAB and 
ureEFGHI) for the biosynthesis of a nickel containing enzyme, the urease, that hydrolyzes the 
urea present in the stomach to ammonia and CO2, buffering the pH of the periplasm (Weeks, 
2000). It was demonstrated that urease-deficient H. pylori are not able to colonize the stomach 
(Eaton, 1991). Even if urease is a cytoplasmatic protein, is it possible to found it on bacterial 
surface, due the lysis of some organisms (Phadinis, 1996), and the protein amount may reach as 
much as 10% of total bacterial protein (Montecucco, 2001). Therefore, urease is one of the most 
common bacterial antigens (Del Giudice, 2001). It has been suggested that the external urease 
protects the bacteria from the low pH of the stomach, creating a cloud of ammonia around it 
(Scott, 1998; Stingl, 2002). The activity of cytoplasmic urease is regulated by a urea channel 
(UreI). This regulation is necessary to avoid over-alkalization, lethal for the bacteria (Clyne, 
1995). Urease is a dodecamer composed by six subunit of UreaA (HP0073) and six of UreaB 
(HP0072), forming a 600kDa molecular complex (Ha, 2001). The formation of this complex and 
its activation/inhibition is regulated by UreaE (HP0070), UreaF (HP0069), UreaG (HP0068) and 
UreaH (HP0078). Another characteristic system, which regulates the activity of urease and is a 
low pH sensor (Pflock, 2004), is the ArsRS system, essential for growth in vivo (Schar, 2005). ArsS 
(HP0165) is a histidine kinase that, in acidic stress conditions, phosphorylates an OmpR-like 
reponse regulator, ArsR (HP165). The genes regulated by this system are membrane proteins, 
Ni2+ storage proteins, detoxifying enzymes and H. pylori specific proteins of unknown function.  
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Other well characterized transcription regulators for acidic resistance are NikR (HP1338) and Fur 
(HP1027). Fur is a ferric uptake protein and is a transcriptional factor that controls intracellular 
iron homeostasis through the expression of iron-uptake and iron-storage genes (van Vilet, 2002; 
Delany, 2001). At low pH and in the presence of Ni2+, NikR acts as a nickel-regulator that directly 
represses several genes such as Fur (van Vilet, 2002), but also activates other genes (Contreras, 
2003), preventing the emergence of toxic nickel concentrations (Dosanjh, 2006). In general, the 
outer membrane composition of H. pylori plays a key role in acid adaptive response, thanks to a 
pH sensor system (Pflock, 2006).  
 
Colonization and interaction with epithelium cells of gastric mucosa 
H. pylori colonization of human gastric mucosa is mediated by a predominant virulence factor, 
the flagellar motility associated to chemotaxis (Kavermann, 2003). To avoid its discharge in the 
intestinal tract by peristalsis, the bacteria establish a persistent infection inside the viscous 
gastric mucus film that covers the gastric epithelium. For this reason H. pylori requires more 
than fifty putative proteins for the expression, secretion and assembly of polar helicoidal-shaped 
flagella, composed by a basal body, which include the rings, motor and switching proteins, a 
hook and a filament. The major proteins involved are FlaA and FlaB that are the copolymer 
filament subunits (Haas, 1993). Even if their genes are located in different positions on the 
chromosome (Suerbaum, 1993), both are necessary for full motility (Josenhans, 1995). FlgE is 
the structural component of the hook, as well as FliD that constitutes the capping of the 
filament. Many other proteins are involved in flagella biosynthesis, assembly and chemotaxis, 
but little is known about them (O'Toole, 2000). The chemotactic factors, such as urea and 
bicarbonate ions (Yoshiyama, 1999) associated to the enzymatic ability to disrupt the oligomeric 
structure of mucin (Windle, 2000), allow H. pylori to move and colonize its gastric niche. To bind 
to epithelial cells, H. pylori uses fucosylated glycoproteins and sialylated glycolipids as cellular 
receptors (Mahdavi, 2002). BabA (HP1243) and SabA (HP0725) are two outer membrane 
proteins that present strong allelic variation, producing different bonding models to modulate 
the adhesion molecules by multiple mechanisms. It has been shown that BabA heterogeneity 
among Helicobacter strains was associated to different clinical outcomes, while SabA positive 
status has been inversely related to the ability of the stomach to secrete acids (Yamaoka, 2006). 
The adherence of H. pylori could be regulated to avoid regions of stomach epithelium where the 
host defense response is more vigorous. Another phase variable outer membrane protein, OipA 
(HP0638), identified as a potential colonization factors, is associated to severe outcomes, 
duodenal ulceration and gastric cancer.  
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The ability of H. pylori to move through the mucus layer by its flagella facilitates a better access 
to nutrients and the delivery of effectors molecules, that are fundamental steps in the 
colonization of human gastric mucosa. 
 
Virulence factors 
The most severe clinical outcomes are always associated to cag+ strains (Parsonnet, 1997). cag-
PAI is defined as the “Cytotoxic Associated Genes Pathogenicity Island” and it consists of a 
characteristic chromosome region of about 40 kb containing around 28-29 genes, flanked by 
transposable elements (Censini, 1996; Tomb, 1997; Haker, 2000).  Some cag-PAI genes encode 
proteins that form the “Type four secretion system” (T4SSs), which allows the delivery of 
proteins and/or DNA in the host, influencing its homeostasis. The best characterized secreted 
protein is CagA, which becomes phosphorylated by endogenous kinases and modulates host cell 
functions by interfering with cell signaling. CagA is considered a bacterial oncoprotein 
(Hatakyama, 2004 and 2006) because the interaction of CagA with host proteins induces 
multiple cellular events that include morphogenetic changes and may lead to malignant 
transformations (Tummuru, 1993; Covacci, 1993; Hatakeyama, 2005). 
Another important virulent factor, which gives a competitive advantage to H. pylori, is the 
vacuolating cytotoxin A, known as VacA (HP0887). When secreted, it induces the formation of 
large cytoplasmic vacuoles in gastric cultured cell lines (Leunk, 1988; Cover, 1992). VacA is a 
multi-globular protein composed by two domains, p33 and p55, forming a mature toxin whose 
structure seems a “flower” with a central ring surrounded by “petals”. In condition of low pH, 
the dissociation of this complex is observed, favoring the entrance of the monomer in lipid host 
cellular membranes by forming a hexameric anion-specific channel (Cover, 1997). The effects 
produced by this toxin are related to the alteration of antigen presentation (Molinari, 1998), 
inhibition of T-cell activation and proliferation (Boncristiano, 2003) and apoptosis induction 
(Galmiche, 2000).  
H. pylori pathogenic strains express a protein that is able to activate neutrophiles, HP-NAP. This 
protein promotes the adhesion of human neutrophiles to endothelial cells and simulates the 
production of reactive oxigen species (ROS) (Yoshida, 1993). The structure of this protein reveals 
a four-helix bundle protein that oligomerizes to form a dodecamer containing a negatively 
charged cavity (Zanotti, 2002). In spite the protein ability to store up to 500 iron atoms, it has 
functionally evolved as a leukocyte activator able to induce mucosal damage, though neutrophils 
activation (Montecucco, 2001). 
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H. pylori and gastroduodenal disease 
H. pylori infection is usually associated to an increase of the risk of different severe pathologies 
including peptic ulcers, non-cardia gastric adenocarcinoma and gastric mucosa-associated 
lymphoid tissue (MALT) lymphoma, even if most of H. pylori infected individuals are 
asymptomatic (Cover, Blaser 2009). The risk of a severe outcome, as peptic ulcers or 
adenocarcinoma, is strongly correlated to the specific infecting strain. In fact, some H. pylori 
strains present typical protein polymorphism associated to the expression of characteristic 
virulence factors that usually interacts with host epithelial cells, increasing the risks for some 
disease. It was demonstrated in different studies that, in particular in Western countries, cag-PAI 
positive H. pylori strains are associated to a high risk of peptic ulcers disease, premalignant 
gastric lesion, and gastric cancer (Basso, 2008). A more particular protein pattern analysis was 
performed to the major pathogenic protein factors. The correlation with the number of CagA 
tyrosine phosphorylated (EPIYA) motifs, as well as the expression of an active form of 
vacuolating cytotoxin VacA in vivo is predictive of gastric cancer risk (Higashi, 2002). Often 
strains that express BabA and OipA OMPs are associated to a higher risk of disease than the 
strains that lack these factors (Cover, 2009). 
The stomach cancer is usually diagnosed between the ages of 50 and 70 years, excluding 
hereditary cases in which is possible to observe younger cases more frequently. The 
geographical distribution of this disease also reflects a higher prevalence in certain world areas, 
such as Japan, Korea and China (Hatakeyama, 2009). The gastric cancer has been histologically 
classified in two types, the first one associated to environment perturbations and the second 
more related to host genetic predisposition. It has been demonstrated that H. pylori plays a key 
role in both type of gastric carcinomas (Uemura, 2001), and that there is a correlation between 
the dominant form of intestinal-type and H. pylori cag+ strains (Blaser, 1998). 
During H. pylori infection, there is an activation of the immune response of the host that attracts 
and activates neutrophils, which release ROS. This response provokes a perpetuation of 
inflammation, and oxygen radicals may cause a wide range of cellular damages that can be 
associated to the stimulation of malignant B cells growth in MALT lymphoma (Farinha, Gascoyne 
2005).   
Gastroesophageal reflux has also been associated to H. pylori infection. In fact, motor alteration 
of esophageal sphincter (Penagini, 2002) should be correlated to esophagus cells damage. The 
increase of gastric juice secretion, hydrochloric acid and pepsin were identified as the most 
important factors in the induction of reflux esophagitis. The secretion of gastrin by endocrine G 
cells is stimulated by gastric mucosal interleukins IL-8 and IL-1b, as a consequence of H. pylori 
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inflammatory response (Souza, 2009). 
Recently it was also demonstrated that the motility of H. pylori is a critical virulence 
determinant, since it enhances the effects of SabA, during the adherence of the bacteria to the 
epithelial gastric cells, increasing the bacterial density to trigger higher inflammatory response 
(Chen-Yen K, 2012). 
 
Therapy of H. pylori infection 
The first-line therapy, in population with less than 15-20% clarithomycin resistance rate, consists 
of a triple therapy, constituted by a proton pump inhibitor (PPI), clarithromycin and moxicillin or 
metronidazolein (Malfertheiner, 2007). The most serious problem is represented by the increase 
of H. pylori resistant strains (D'Elios, 2007). To avoid this problem, the development of a vaccine 
represents a possible solution. Several approaches have been devised to generate an effective 
vaccine against the bacterium. Two generations of vaccine have been generated, the first 
consisting in the whole bacterial sonicated cells, and the second by H. pylori isolated proteins 
that are processed and used by antigens to simulate immunity in host. They latter needs 
adjuvants to elicit effective protection. Even if the studies on animal models have been 
extensive, the human successful cases are limited. About human trials, the most successful trial 
used the bacterium Salmonella typhi carrying H. pylori antigens or inactivated H. pylori cells. In 
this case S. typhi was deleted of virulence genes and modified to consecutively express H. 
pylori’s urease, then this vector was orally administrated to 8 uninfected volunteers, but it was 
ineffective in producing any detectable mucosal or humoral immune response to urease antigen 
(DiPetrillo, 1999). Changing the bacterial vector in S. tiphimurium, better results were observed 
in some human volunteers, who produced some antibody against urease (Angelakopulos, 2000). 
Another vaccine against H. pylori tested on human uninfected volunteers was a Salmonella 
prophylactic Ty21a(pDB1), which displayed moderate efficacy but no major adverse effects 
(Bumann, 2001). Oral inactivated H. pylori whole cell vaccine induced a specific B-cell response, 
but could not eradicate the bacterium from infected individuals, showing prophylactic but not 
therapeutic efficacy (Losonsky, Kotoloff, 2003). 
Vaccinologists are now going to test new forms of vaccine based on live vectors, for instance 
DNA vaccines, which carry DNA sequences encoding H. pylori antigens, increasing safety and 
efficacy. The microsphere vaccines are able to induce humoral and mucosal immunity as well as 
mediated immunity. Bacterial ghost vaccines simulate the native antigenic structures, since they 
are constituted by empty cell envelopes without cytoplasmic contents, preserving cellular 
morphology (Agarwal, 2008).  
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While the development of an efficient vaccine against H. pylori is now the aim of many 
researchers, the search for new specific antibiotics as a new pharmaceutical target is required 
for the complete eradication of H. pylori. 
  
31 
 
Chapter 2 
Mol Microbiol. 2013 Dec 12;PubMed PMID: 24330328. 
Helicobacter pylori  periplasmic receptor CeuE (HP1561) modulates its 
nickel affinity via organic metallophores  
Md Munan Shaik,†§ Laura Cendron,‡§ Marco Salamina, Maria Ruzzene and Giuseppe Zanotti* 
Department of Biomedical Sciences, University of Padua, Viale G. Colombo 3, 35131 Padua, Italy. 
 
Abstract 
 
Introduction 
 
Materials and methods 
Molecular cloning  
Overexpression and affinity purification  
Crystallization and structure determination  
CeuE site-directed mutagenesis  
Fluorescence measurements  
Surface Plasmon Resonance Analysis 
 
Results and Discussion 
The overall Model  
Interaction with the ABC transporter  
Ligand-binding Assays  
Ni
2+
 coordination studies  
The binding cleft and mutagenesis studies  
Variability among strains 
 
Conclusions 
  
32 
 
 
  
33 
 
Abstract 
In Gram-negative bacteria, nickel uptake is guaranteed by multiple and complex systems that 
operate at the membrane and periplasmic level. H. pylori employs other yet uncharacterized 
systems to import the nickel required for the maturation of key enzymes, such as urease and 
hydrogenase. H. pylori CeuE protein (HP1561), previously annotated as the periplasmic 
component of an ABC-type transporter apparatus responsible of heme/siderophores or other 
Fe(III)-complexes uptake, has been recently proposed to be on the contrary involved in 
nickel/cobalt acquisition. In this work, the crystal structure of H. pylori CeuE has been 
determined at 1.65Å resolution using the SAD method. It comprises two structurally similar 
globular domains, each consisting of a central five-stranded β-sheet surrounded by α-helices, an 
arrangement commonly classified as a Rossmann-like fold. Structurally, H. pylori CeuE belongs to 
the class III periplasmic substrate-binding protein. Both crystallographic data and fluorescence 
binding assays allow to exclude a role of the protein in the transport of VitB12, enterobactin, 
heme and isolated Ni2+ ions. On the contrary, the crystal structure of the protein/Ni2+(L-His)2 
complex suggests that H. pylori CeuE binds and transport nickel in vivo thanks to the formation 
of a Ni2+/histidine complex.  
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Introduction 
In gastric Helicobacter species nickel represents an essential cofactor of key enzymes, such as 
urease and NiFe-hydrogenase. Reduced availability of nickel causes urease inactivation and 
consequent reduced capability of buffering the acidic pH of the gastric lumen, one of the 
primary bacterial defenses against such hostile environment. On the other hand, hydrogenase 
inactivation due to nickel paucity impairs the opportunity of Helicobacter to use the hydrogen 
available in the gastric mucosa as a respiratory substrate and strongly limits its colonization 
efficacy (Olson et al., 2002). The availability of such transition metal should be guaranteed by 
uptake systems at the outer membrane level implying the capture of nickel ions and transport 
trough the membranes. The subsequent incorporation of metal ions into nickel-dependent 
enzymes requires complex assembly processes and multiple accessory proteins. While a class of 
porins guarantee the uptake of complexed nickel ions at the outer membrane level (OMPs), two 
main routes are known to be used by bacteria to import nickel over the inner membrane, one 
involving an integral membrane high-affinity permease, the other defined by specific ABC-type 
transporter systems (Mulrooney et al., 2003). H. pylori NixA permease has been identified 
(HP1077) and demonstrated to mediate the import of nickel through the cytoplasmic membrane 
(Bauerfeind et al., 1996), whilst NikH guarantees at the outer membrane level the availability of 
nickel to the permease (Stoof et al., 2010a). NixA expression is regulated by NikR (nickel-
responsive regulator) and repressed in the presence of high nickel concentrations, to avoid toxic 
overload (Wolfram et al., 2006). However, urease activity in a NixA deletion mutant is reduced 
but not abolished, thus implying the presence of an alternative nickel transporter (Nolan et al., 
2002). It has been also postulated that H. pylori uses the ExbB/EsbD/TonB transport system to 
import nickel complexed by an unknown nickelophore captured from the environment (Schauer 
et al., 2007). Very recently, the Ni(L-His)2 complex has been identified as a substrate for the 
NikABCDE-dependent uptake of nickel in Escherichia coli (Chivers et al., 2012; Lebrette et al., 
2013). 
Recently it has been proposed, using H. mustelae as a model of gastric species that colonizes 
ferrets stomach, that CeuE and FecD/E proteins represent an ABC-type transporter system that 
mediates an alternative route for the nickel/cobalt acquisition (Stoof et al., 2010b). Indeed, 
despite being previously classified as proteins involved in the iron uptake, inactivation mutants 
of each of them did not alter significantly the iron levels in the bacterial cells and, on the 
contrary, clearly reduce urease activity and nickel content.  
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The protein coded by gene hp1561 (CeuE) was annotated as periplasmic iron-binding protein 
and as a component of an Fe(III) ABC transporter. Contradictory experimental data concerning a 
putative involvement in the iron acquisition processes have been accumulated in the literature: 
it was found to be iron-regulated during the stationary-phase, along with many other genes 
(Merrell et al., 2003), but the transcription of such genes as well as those coding for the 
cytoplasmic ABC-transporter components FecD and FecE is not repressed by iron, and is also not 
affected by mutation of gene fur (Delany et al., 2001a; Delany et al., 2001b; van Vliet et al., 
2002). In a recent work aimed at identifying the presence of natural antisense transcripts in H. 
pylori, a new small non-coding RNAs complementary to mRNAs of CeuE have been discovered 
(Xiao et al., 2009), suggesting that metal homeostasis can be regulated by alternative strategies, 
as hypothesized in other cases such as ferritins (Bereswill et al., 2000; Xiao et al., 2009). 
Following the recent model of a novel nickel/cobalt specific ABC-type transporter working 
independently from NixA, a role of nickel receptor could be hypothesized for CeuE protein in this 
contest. Indeed, due to its sequence similarity to periplasmic substrate-binding proteins present 
in both Gram-negative and Gram-positive bacteria, it can be proposed that CeuE could capture 
nickel/cobalt ions (Ni2+/Co2+) or nickel/cobalt complexes, available in the periplasm thanks to 
outer membrane porins and deliver the substrate to the translocator, defined by the FecD/E 
inner membrane importer.  However, a direct proof of such a role is lacking and the nature and 
specificity of the actual CeuE ligands remain unclear.  
To elucidate the structural features of this periplasmic ABC-type transporter binding protein and 
possibly characterize the nature and affinity toward putative substrates, CeuE receptor coded by 
gene hp1561 from H. pylori has been cloned in E. coli, expressed, purified, crystallized, and its 
structure determined both in the absence and presence of nickel ions. In vitro binding activity 
with different possible metal ions and metal-containing compounds has been characterized. 
 
Materials and Methods 
Molecular cloning   
HP1561 gene was amplified by PCR from H. pylori G27 genomic DNA, using proofreading pfu 
DNA polymerase (Finnzymes, Finland), with the following primers: 5’- CAC CAT GGA AGT CAA 
AGT TAA GGA TTA TTT CG (Forward) and 5’ CCA TAA GAA TGG CTC AAC TTC TGC GTC (Reverse), 
which amplify from 33 to 332 amino acids from total length 333 amino acids with N-terminal 
signal peptide/transmembrane helix deletion (32 amino acids) and one His deleted from C- 
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terminal. The amplified fragment was cloned into the pET101vector (Invitrogen) in frame with a 
C-terminal His-tag, using a TOPO® Cloning kit by Invitrogen to obtain the pET101-HP1561 
plasmid. Right insertion in the cloned vector was confirmed by colony PCR and by sequencing 
with T7 forward and reverse primer.  
Overexpression and affinity purification 
E. coli BL21(DE3) cells (Novagen) were transformed with the pET101-HP1561 plasmid and grown 
in LB media at 37° C, supplemented with Ampicillin (100 µg/ml). Protein expression was 
triggered by 1 mM isopropyl-β-D-thiogalactoside (IPTG, Inalco) till the culture reached an optical 
density (OD600) of 0.7. After 4h incubation at 28° C, bacteria were collected and resuspended in a 
lysis buffer (30 mM Tris, pH 8.0, 150 mM NaCl) and then disrupted by a One Shot Cell breakage 
system at 1.35psi (Constant System Ltd., UK). The lysate was centrifuged to remove cell debris 
(18,000 g for 25 min) and loaded into a column containing 5 ml of Ni2+ charged Chelating 
Sepharose™ (GE Healthcare, UK). After extensive washing using the lysis buffer, supplemented 
with 20mM imidazole, the protein was eluted by a linear gradient from 80 to 300 mM imidazole. 
The protein was further purified by gel filtration, using a Superdex 200™ 16/60 GL (GE 
Healthcare) equilibrated with 30 mM Tris pH 8.0, 150mM NaCl. HP1561-His tagged eluted as a 
single peak. All the protein samples collected throughout the purification were separated and 
analyzed on 15% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). The 
resolved gels were stained with 0.25% Coomassie Brilliant Blue R250 reagents. 
Molecular mass of CeuE protein was determined by analytical gel filtration using an analytical 
column Superdex 200™ 10/300 GL (GE Healthcare), operated on an AKTA FPLC instrument (GE 
Healthcare). 
To prepare the seleno-methionyl protein, the plasmid pET101 containing the HP1561 gene was 
transformed into the methionine auxotrophic E. coli strain B834. The transformed bacteria were 
grown in M9 minimal medium supplemented with 0.4% (w/v) glucose, salts and all the amino 
acids except Met, substituted by Se-Met (50mg/L). About 30 minutes before induction with 0.3 
mM IPTG, a further solution of Se-Met plus Leu, Ile, Val, Phe, Lys and Thr was added to the 
medium to inhibit the E. coli methionine pathway and to force the incorporation of Se-Met. The 
HP1561 Se-Met derivative was purified as the native protein, with enhanced content of reducing 
agent in buffer (5 mM DTT), to prevent oxidation. CeuE-H197L mutant was expressed and 
purified in the same conditions applied for the wt protein, obtaining analogous yield and 
pureness. 
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Crystallization and structure determination  
The purified protein was concentrated to 50 g/l and used for crystallization tests, partially 
automated using an Oryx 8 crystallization robot (Douglas Instruments). Crystals grew in several 
conditions. The best native crystals were obtained at 293 K by vapor diffusion technique using a 
20 g/l protein stock solution and, as precipitant, a solution containing 0.1 SPG Buffer pH 8.0, 25% 
(w/v), PEG 1500 (The PACT Suit, solution n. 5, Qiagen, USA). Crystals could be processed as 
orthorhombic, space group P212121, with unit cell dimensions a=67.37 Å, b=87.02 Å, c=105.90 Å. 
Two monomers are present in the asymmetric unit, with VM= 2.3Å
3/Da, corresponding to an 
approximate solvent content of 47%. A diffraction data set was measured at the beamline ID29 
of the European Synchrotron Radiation Facility (ESRF), Grenoble, France. Crystals of Se-Met 
derivative were grown in the same condition and a SAD dataset was measured at the beamline 
ID14-4 of ESRF. To explore the metal coordination in the metal binding site, CeuE crystals were 
grown in the presence of 10mM NiSO4 in the precipitant solution (0.5 M Sodium Formate, 0.1 M 
Bis Tris Propane, pH 7.5, 20 % (w/v) PEG 3350), by sitting-drop vapor diffusion at 200C. They 
belong to the monoclinic P21 space group with unit cell dimensions a= 60.18 Å, b=76.95 Å, 
c=72.78 Å, β=94.52 Å. Nickel anomalous data were measured at the beamline ID 23-1 of ESRF at 
the wavelength of 1.48520 Å. Furthermore, a purified CeuE protein solution (0,006 mM) was 
treated with a buffered NiCl2 solution (0,6 mM), in the presence of a three fold excess of L-
histidine, in order to obtain a Ni(L-His)2 complex. The sample was concentrated to 10 g/l, further 
enriched with the metal complex to maintain a 10 fold excess and tested by sparse matrix 
crystallization screenings (Structure Screen I and II, Molecular Dimension Limited, and PEG’s 
Screen, Qiagen) at 293 K, in a vapor-diffusion setup. Diffraction quality crystals were obtained in 
multiple conditions, the best resulting PEGsII n.45 (0,2M Lithium Cloride, 0,1M Tris pH 8,5 30% 
w/v PEG 4000) and PEGsII n.72 (0,1M Lithium Cloride, 0,1M Tris pH 8,5 32% w/v PEG 4000). The 
CeuE Ni2+-histidine containing crystals belong to the same space group as those grown with 
NiSO4, with analogous cells parameters. 
All the datasets were indexed and integrated with software Mosflm (Leslie,2006) and merged 
and scaled with Scala (Evans,2006), contained in the CCP4 crystallographic package 
(Collaborative Computational Project, Number 4,1994). The structure was solved by 
experimental phasing using the selenium dataset, in which position of selenium was explored by 
Autosol and further model building with extension to high resolution native dataset with 
Autobuild (Adams et al., 2009). Model building was further extended with Buccaneer 
(Cowtan,2006) and manual rebuilding with graphic software Coot (Emsley et al., 2004). 
Refinement was carried on using package Phenix (Adams et al., 2010), and Refmac (Murshudov 
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et al., 1997). The final crystallographic R factor is 0.198. (Rfree 0.239). All the putative complexes 
including the different nickel compounds were solved by molecular replacement using the 
software Phaser (McCoy et al., 2007) or Molrep (Vagin et al., 1997), starting from a monomer 
model of HP1561 and refined by Refmac. Solvent molecules were added with the automated 
procedure of Phenix, followed by manual inspection and small adjustments with the software 
Coot. Geometrical parameters of the models, checked with software Procheck (Laskowski et al., 
1993), are as expected or better for this resolution.  
CeuE site-directed mutagenesis  
Single point mutation of the CeuE gene was performed with the QuickChange Site-Directed 
Mutagenesis Kit (Stratagene), using pET101-HP1561 plasmid as template. Oligonucleotides to 
introduce the mutation were designed as following (Sigma-Aldrich): mutH197Lfw (5’- AAA GGG 
GTG GAG CTT TTC CTT AAG GCC AAT AAG ATT AGC -3’) and mutH197Lrv (5’- GCT AAT CTT ATT 
GGC CTT AAG GAA AAG CTC CAC CCC TTT -3’). The insertion of the required mutation in the 
resulting plasmid (pET101-HP1561-H197L) was verified by sequencing.  
Fluorescence measurements 
Tryptophan fluorescence quenching upon ligand binding was measured with a Perkin Elmer 
LS50B Fluorescence Spectrophotometer. Each titration was performed in a 2 ml quartz-cuvette 
thermostated at 298 K, using an excitation wavelength of 295 nm and an emission wavelength of 
340 nm and slits width adjusted to 5 nm. An equilibration time of 3 minutes has been applied 
after each substrate addition, before acquiring the fluorescence signal. Both CeuE wild type 
protein and CeuE H197L mutant have been diluted to 0.5µM in Tris 30mM, NaCl 150mM, pH 7.5 
before titration, while increasing amounts of each ligand were added stepwise, exploring a 
concentration range between 1 and 100 µM for hemin, enterobactin and Vitamin B12, while 
nickel chloride, nickel-EDTA and nickel-(His)2 were added till 50µM. Iron-enterobactin complex 
was prepared starting from iron-free enterobactin dissolved in DMSO and a FeCl3 stock solution 
according to Zawadzka et al. (Zawadzka et al., 2009). Ni(His)2 and nickel-EDTA were prepared 
treating a nickel chloride stock solution with a large excess of EDTA or histidines (molar ratio 
1:2). Fluorescence data were fitted using a non-linear regression analysis by the software 
GraphPad Prism version 6. Best fitting of the fluorescence curves and the corresponding 
dissociation constants were calculated using a one-site and single type of binding model for all 
the substrates tested, using the general quadratic equation as reported in van de Weert and 
Stella (van de Weert et al., 2011). The molar fluorescence of the free ligands was estimated by 
linear regression, in the same conditions of the binding tests. 
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Surface Plasmon Resonance Analysis  
A BiacoreTM T100 (GE Healthcare) instrument was used. CeuE was covalently coupled to a CM5 
(series S) sensor chip (carboxymethylated dextran surface) by amine-coupling chemistry to a 
final density of 3700 resonance units (RU), as described in (Ruzzene et al., 1999); a 10 mM 
acetate, pH 5.0 buffer was used for the immobilization. A flow cell with no immobilized protein 
was used as control. Binding analysis was carried out in a running buffer consisting of 10 mM 
HEPES, pH 7.4, 150 mM NaCl, 0.05 % (v/v) Tween-20, applying a flow rate of 10 µl/min. Each 
sensorgram (time course of the surface plasmon resonance signal) was corrected for the 
response obtained in the control flow cell and normalized to baseline. After each injection the 
surface was regenerated by a double injection of 1M NaCl for 30 sec; this treatment restored the 
baseline to the initial resonance unit value. For kinetics experiments, a Biacore method program 
was used that included a series of three start up injections (running buffer), zero control 
(running buffer) and 5 different concentrations (ranging between 0.05 and 10 μM, one of which 
in double) of Ni-(L-His)2 or vitamin B12. Serial dilutions of the analyte were performed in running 
buffer from a 25 mM top concentration. High performance injection parameters were used; the 
contact time was of 480 s followed by a 480 s dissociation phase. The kinetic data were analyzed 
using the 2.0.3 BIAevaluation software (GE Healthcare). Curves were fitted with the classical 
Langmuir 1:1 model; the quality of the fits was assessed by visual inspection of the fitted data 
and their residual, and by chi-square values. Two independent experiments were performed. 
 
Results and Discussion 
The overall Model  
The crystal structure of H. pylori CeuE (HP1561) was determined at 1.65Å resolution using 
phases obtained from single anomalous dispersion method. The model could be built from 
amino acids 33 to 335 (the protein expressed starts at residue 33, since the first 32 amino acids 
represent a putative secretion signal). The electron density for main chain atoms is always 
continuous and very well defined, with the exception of few residues (103-107) in the loop that 
connects strand β5 to helix α6. This happens for both molecules present in the asymmetric unit, 
an indication that this area is intrinsically flexible. H. pylori CeuE consists of two structurally 
similar globular domains, a N-terminal (33-165) and a C-terminal domain (187-335), each 
consisting of a central five-stranded β-sheet surrounded by α-helices, also known as a 
Rossmann-like fold (Figure. 2.1). The two domains are topologically similar and a long, rigid α-
helix (α10, 166-186) acts as an inter-domain linker (Figure. 2.2). H. pylori CeuE was classifies as a 
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class III periplasmic substrate-binding protein (SBP). Its overall fold shares structural features in 
common with PhuT and ShuT, two heme-transport proteins from Pseudomonas aeruginosa (PDB 
ID: 2R79) and Shigella dysenteriae (PDB ID: 2R7A), respectively (Ho et al., 2007). Other structures 
of the same family include BtuF, a vitamin B12 transport protein from E. coli (PDB ID: 1N2Z, 
(Borths et al., 2002)), FhuD, a periplasmic siderophores binding protein from E. coli (PDB ID: 
1K7S, (Clarke et al., 2000)) and HmuT, a periplasmic heme binding protein from Yersinia pestis 
(PDB ID: 3NU1, (Mattle et al., 2010)). Two hemes are bound in the heme-binding cleft of the 
latter, which also presents a more extended groove to accommodate the heme. 
A  B  
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r.m.s.d. Å  PDB ID 
4.2 (292) 2ETV 
2.5 (246) 2R79 
3.0 (261) 3GFV 
2.7 (238) 2RG7 
3.1 (254) 3LI2 
2.3 (231) 1N2Z 
2.6 (252) 2XUZ 
3.0 (253) 2CHU 
3.3 (231) 3NU1 
Figure. 2.1 A) Topology diagram of H. pylori CeuE. B) Overall cartoon of the monomer. α-helices are in red, β-
strands in yellow, others in green, the long α-helix connecting the two domains in cyan. C) H. pylori CeuE 3D 
Structure alignment (Dali) with other SBPs family members. 
 
The three-dimensional structures of the members of the periplasmic binding 
proteins family most similar to H. pylori CeuE are listed in Figure 2.1 C. The r.m.s.d. 
between equivalent Cα atoms ranges from 2.3 Å to 4.2 Å. The sequence similarity 
among members of the family is quite low and only five residues are fully conserved: 
two surface-exposed glutamates (E110 and E236), one in each lobe, and three other 
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residues (Pro 117, Glue 118 and Pro 243) (Figure 2.2). They could possibly denote 
the structural features of this family. Although almost all of the secondary structure 
elements described in the other members of the protein family are conserved in H. 
pylori CeuE, some extra features are present in the latter. Two antiparallel β-strands 
(34-49), present in the N-terminal domain, are absent in PhuT, ShuT, and BtuF, but 
they are present in the putative Fe(III) ABC transporter from Thermotoga maritima 
(tm0189, PDB: 2ETV) and in other siderophore binding proteins, such as FeuA from 
Bacillus subtilis (PDB: 2XUZ, (Peuckert et al., 2011)), HtsA from Staphylococcus 
aureus (PDB: 3LI2, 3EIW, (Grigg et al., 2010)) and ferric enterobactin binding protein 
from Campylobacter jejuni (PDB: 2CHU, (Muller et al., 2006)). There is also a C-
terminal extension, present only in 2ETV, containing three α-helices (α18, residues 
302-306; α19, 309-323, and α20, 325-330). In fact, H. pylori CeuE is longer in 
sequence (335 amino acids) if compared to ButF (266), PhuT (308) and ShuT (277), 
but smaller than 2ETV (356).  
 
Figure. 2.2 Amino acid sequence alignment of CeuE homologues from different species. 
 
Two loops at the surface of the N-terminal domain of the structure of HP1561 
display quite high B-factors. These two loops are composed of residues 101-116 and 
126-138 (Figure 2.3). The elevated B-factor was reported to be present in other 
members of this class III periplasmic binding proteins: three loops with similar 
features are present at the surface of the C-terminal domain of the crystal structure 
of siderophore receptor HtsA from Staphylococcus aureus (PDB: 3LI2, 3EIW), which 
is described as an open form of the protein, whilst residues in this three loops have 
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lower B-factors in a close form of the protein, crystallized in a different space group 
(Figure 1) (Grigg et al., 2010). Referring to the crystal structure of HtsA, the H. pylori 
structure can be defined as an open form. Similar high B-factors in the residues at 
the surface of these two loops are present also in the periplasmic heme-binding 
protein ShuT and PhuT. In addition, the C-terminal domain of ShuT has a small-
extended loop (residues 168-173) that presents quite high B-factor and which 
extends over the substrate binding site. It can be speculated that this loop is flexible, 
acting as a gate for the substrate-binding site. This extended extra loop is absent in 
the structure presented here, leaving the gate open for the entrance of the ligand.  
 
Figure. 2.3 Ribbon drawing of the monomer of H. pylori CeuE. The diameter of the ribbon tube is 
proportional to the thermal parameters of the atoms.  
 
Interaction with the ABC transporter 
Two CeuE molecules, oriented face-to-face facing the binding cavity, are present in 
the asymmetric unit in the orthorhombic space group. Two molecules are also 
present in the monoclinic crystal cell, but oriented in a different way, a strong 
indication that the two molecules do not correspond to a physiological dimer.  
BtuCD is an adenosine triphosphate–binding cassette (ABC) transporter that 
translocates vitamin B12 from the periplasmic binding protein BtuF into the 
cytoplasm of E. coli. The crystal structure of the overall complex is known (Hvorup et 
al., 2007). The monomer of H. pylori CeuE crystal structure can be superimposed to 
BtuF in the crystal structure of the complex with a r.m.s.d. of 2.4 Å (Figure 2.4 A).  
Two conserved, surface-exposed residues, one in each lobe of the protein, Glu110 
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and Glu236, are present in the same place in the two proteins and they interact with 
two positively charged residues (Arg295 and Arg59) on the surface of BtuCD (Figure. 
2.4 B). In addition, in the theoretical model of HP0889, the putative ABC transporter 
partner of H. pylori CeuE, the two positively charged residues considered crucial for 
the formation of the BtuF/BtuCD complex are conserved. The flexibility of the 
exposed surface loops in the N-terminal domain of H. pylori CeuE, involved in the 
interaction with the putative ABC transporter, (residues 101-116, 126-138) might 
play a role in the interaction and/or in substrate translocation. 
 
 
A
 
B
 
Figure. 2.4 A) Cα trace of H. pylori CeuE (blue) superposed to E. coli BtuF in complex with BtuCD 
(PDB ID 2QI9). Side chains of residues Glu110 and Glu236 are shown in red. B) Cartoon view of 
BtuCD (the four polypeptide chains are represented in different colors) with H. pylori CeuE (blue) 
replacing BtuF. On the right side a detail of the interaction region shows the two negatively 
charged glutamate residues (red) interacting with the positively charged arginines (magenta).  
Ligand-binding Assays  
Since the 3D structure of H. pylori CeuE presents a similarity to the protein family 
that includes periplasmic heme-binding proteins, periplasmic siderophore receptors 
and Vitamin B12 binding proteins, binding assays were performed with the following 
compounds: hemin, enterobactin and VitaminB12, and with Ni2+ ions in the presence 
of histidine as a chelating agent. Indeed, the possibility to acquire such transition 
metal if complexed by two histidine ligands, Ni-(L-His)2, has been recently 
demonstrated for E. coli NikA periplasmic receptor (Chivers et al., 2012). Later, the 
structure of E. coli NikA protein has been crystallized either in complex with Ni-(L-
His)2 or as purified from the bacterium. In the latter case, a still unidentified nickel 
containing complex has been found in the substrate binding cleft, suggesting it could 
represent the physiological nickel chelating ligand (Lebrette et al., 2013). Such 
results reveal that, analogously to iron uptake, nickel acquisition could be 
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guaranteed by receptors that recognize specific nickel complexes, either 
endogenously produced or deriving from the growth medium.   
The binding of hemin, enterobactin and VitaminB12 was tested through quenching 
of intrinsic protein fluorescence, since four tryptophan residues are present in the 
CeuE protein, two of which in the putative binding cavity. A clear fluorescence 
quenching was observed after addition of increasing amounts of heme, vitamin B12 
or enterobactin. The experimental curves concerning the iron-containing 
compounds (Figure 2.5) were better fitted by a non-linear regression, assuming a 
one-site binding model. In the tested conditions, all of the compounds were 
characterized by modest dissociation constants values, in the micromolar range or 
worse, the best resulting hemin (18.3 ± 0.4 μM).  
 
Figure 2.5. Fluorescence titrations with iron-containing complexes, plotted as fluorescence signal 
against increasing concentration of substrate. Top panels left and right correspond to titration of wt-
CeuE and CeuE-H197L mutant with heme, while bottom panels left and right of wt CeuE with vitamin 
B12 and enterobactin, respectively.  
In the case of nickel containing compounds, since the fluorescence quenching values 
are significantly altered owing to the absorption of the fluorescence signal at 330 nm 
by nickel ions (Shepherd et al., 2007), the estimation of the binding constant was 
performed by surface plasmon resonance analysis. Analysis of the sensograms 
(Figure. 2.6 A) gives for the Ni-(L-His)2 complex a KD = 0.79 μM (±0,08 µM). In order 
to derive, using the same technique, a value for the other ligands, the experiment 
was repeated with heme, enterobactin and vitamin B12. A significant curve could be 
obtained only with the latter, owing to aggregation phenomena with the others two. 
The binding curve of Vitamin B12 (Figure. 2.6 B) indicates that this complex is quite 
labile, such that it was not possible to estimate a reliable value for the binding 
constant. Since fluorescence data point to values in the same range for Vitamin B12, 
heme and enterobactin, they allow excluding an involvement of CeuE in the VitB12 
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transport, as well as a capability to recruit Fe(III) by siderophores analogous to 
enterobactin or by heme. In addition, crystals grown in the presence of an excess 
concentration of heme and enterobactin failed to show the ligand bound to the 
protein in the crystal. 
 
A  
B  
Figure 2.6 Analysis of CeuE interaction with Ni-(L-His)2 and vitamin B12 by means of SPR signal 
detection. A) Ni-(L-His)2 solutions at the indicated concentrations were injected over the CeuE 
chip for kinetics determination. B) Comparison between Ni-(L-His)2 and vitamin B12. 
 Ni2+ coordination studies 
In order to test if CeuE from H. pylori is directly involved in Ni2+ binding and/or 
transport, crystals of the protein were grown also in the presence of 10 mM Ni2+. 
Three nickel ions were identified in the Fourier-difference anomalous electron 
density map, one of them present in the potential substrate-binding cleft, and other 
two close to the protein surface (Figure 2.7). However, none of the three Ni2+ ions 
are characterized by a specific coordination. They are in general close to some 
negatively charged protein residues (for example, nickel in the substrate-binding site 
interacts with Glu69), but the remaining coordination sites of the metal are occupied 
by acetate or water molecules, suggesting an unspecific interaction of positively 
charged ions with negative side chains of the protein.  
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Figure. 2.7 Unspecific nickel binding to the surface of H. pylori CeuE 
On the contrary, crystals grown in the presence of Ni(L-His)2 show the presence of 
the complex clearly bound inside the CeuE binding cleft (Figure. 2.8). The Ni2+ ion 
presents a slightly distorted octahedral coordination, where five of the coordinating 
atoms belong to the two free histidines, whilst the sixth is a nitrogen atom of His 103 
of the protein. Interestingly, the two free histidines are asymmetrically bound, in a 
different manner if compared with the Ni(L-His)2 complex that is stable in aqueous 
solutions (Lebrette et al., 2013). One of the histidines contributes with three atoms 
to the coordination, two nitrogens from the imidazole ring and from the amine 
group and a carboxylic oxygen, whilst only the amine nitrogen and the carboxylic 
oxygen of the second histidine take part in it. The imidazole ring of this second 
histidine ligand is not involved in the direct coordination of the metal, but is 
oriented toward the entrance of the protein’s binding cavity and establishes 
hydrogen bonds with four water molecules trapped in the same environment. This 
situation leaves the sixth coordination position available to His103 of CeuE. The 
position of the Ni2+ complex inside the protein cavity is stabilized by Arg230, whose 
NH nitrogen interacts with both the carboxylates of the two free histidines and the 
side chain of Asp209, which is buried inside the protein cavity (Figure. 2.8 A). 
It is worth noticing that the binding of the Ni2+ complex, that involves His103, 
induces an ordering of the region 103-107 (Figure 2.8 B), in the loop that connects 
strand β5 to helix α6, which is the only area not well defined in the electron density 
map of the apo-protein. Indeed, the structural features emerging from the 
comparison between apo- and Ni(L-His)2 loaded forms of CeuE allow to hypothesize 
a mechanism where the highly symmetric complex Ni(L-His)2 present in aqueous 
solutions is trapped and reorganized in the CeuE binding cleft through the 
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displacement of the imidazole ring of one of the free histidine ligands by His103, 
which anchors the complex into the binding cavity and breaks the Ni2+ coordination 
symmetry. 
Other two structures of the Ni(L-His)2 complex bound to a bacterial transport 
protein have been determined, NikA from E. coli and from S. aureus (Lebrette et al., 
2013; Minasov et al., PDB ID 3RQT). These two structures present the same fold (the 
r.m.s.d. for the superposition of 402 equivalent Cα atoms is 2.5Å), but the nickel 
adduct binds to them in a completely different way (Figure. 2.8C). In S. aureus NikA 
the Ni2+ does not directly interact with protein atoms, whilst are the latter that 
interact with the histidines coordinating the ion. On the contrary, the binding in the 
case of the E. coli protein is reminiscent of that of H. pylori CeuE (Figure. 2.8 C). In 
both cases, a protein’s histidine residue replaces one of the coordination of the 
metal, despite in a different way: instead of the displacement of the imidazole ring 
of the histidine, in E. coli NikA a histidine carboxylate group is displaced. Residues in 
the two binding cavities are also quite similar, despite differently oriented.  
A
 
B
 
 
Figure 2.8 A) Ni(His)2 complex binding site of CeuE. B) Chain trace of a portion of apo-CeuE 
(orange) and in complex with the nickel-His adduct (green). C) Comparison of the biding sites of 
the Ni(L-His)2 adduct in A) H. pylori CeuE, B) E. coli NikA and C) S. aureus NikA.  
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The binding cleft and mutagenesis studies  
H. pylori CeuE presents significant similarities with heme- or siderophores-binding 
proteins of known structure. A model of CeuE from H. mustelae, the gastric species 
where the involvement of CeuE in the nickel/cobalt uptake has been discovered, has 
been built by homology modeling and superimposed to our structure, showing that 
in the former the His present in the binding cleft and corresponding to H. pylori 
position 103 is conserved, whilst a second histidine present in the biding cavity, 
His197, is replaced by a leucine. In order to test if this substitution is relevant for the 
binding of possible ligands, the mutant of H. pylori CeuE H197L was produced and 
purified. Fluorescence quenching assays (Figure. 2.5), as well as co-crystallization 
trials, shows a behavior very similar to the wild type protein.  
Variability among strains 
H. pylori is characterized by a large genetic variability, and CeuE does not represent 
an exception. The amino acid sequence of H. pylori CeuE is available for 47 different 
bacterial strains. In addition, ceuE gene is duplicated in three strains, 26695, J99 and 
83, bringing to 50 the number of sequences available. They are confined to the 
superficial area of the protein, and only two residues are relatively close to the 
putative binding cleft, Pro253, that in two cases is a threonine, and Asp 209, that in 
some strains is a serine. They both appear not to be in direct contact with the 
hypothesized position of the ligand. The putative region of contact with the ABC 
transporter is also quite conserved, and only three residues are sometimes mutated: 
Val104, that in some strains is threonine, Lys135, that becomes glutamate in strain 
SNT49, and Pro253. 
A special case is represented by strains 908, 2017 and 2018. Strain 908 belongs to a 
patient suffering of ulcer disease and it was isolated in 1998. Strains 2017 and 2018 
represent chronological sub-clones from the same patient isolated about then years 
later (Devi et al., 2010; Avasthi et al., 2011). The sequence of these three genes 
shows long deletions in the C-terminal domain of the protein and the analysis of the 
molecular model suggest that the new protein cannot fold properly, or at least that 
it cannot be able any more to bind the ligand, since it lacks part of the residues 
forming the binding grove. We can conclude that most likely nickel uptake in these 
strains is guaranteed by other routes of metal acquisition that do not imply CeuE 
protein involvement such as the NixA permease one.  
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Conclusions 
In Gram-negative bacteria, nickel uptake is guaranteed by multiple and complex 
systems that operate at the membrane and periplasmic level. Together with NixA 
permease, H. pylori employ other yet uncharacterized systems to import the amount 
of nickel required for the maturation of key enzymes, such as urease and 
hydrogenase.  
The crystal structure presented here demonstrates that H. pylori CeuE (HP1561) 
shows all the distinctive features of the proteins belonging to the class III SBP family. 
In particular, a putative ligand-binding cavity is clearly present in between the two 
protein domains and the protein presents other characteristics of these SBP family 
members, including the residues that define the cleft surface and those that can 
alter the size of the cavity and thus assure the binding and release of the ligand. Co-
crystallization studies in the presence of various potential ligands have shown that 
only a Ni(L-His)2 complex was able to bind inside the putative binding cavity, whilst a 
large excess of nickel ions, despite the presence of three ions bound to different 
sites of the protein surface, seem to exclude a direct coordination of nickel ions, due 
to its unspecific and loose coordination features. At the same time, our results 
exclude specificity of binding toward others ligand of the SBP family, likeVitB12, 
enterobactin or heme. These results are in line with the study of the corresponding 
receptor (Stoof et al., 2010b) in H. mustelae, a gastric species closely related to H. 
pylori, that indicates an involvement of CeuE protein in nickel/cobalt acquisition, 
together with the transmembrane ABC-transporter components FecD/E 
(HP0889/HP0888). Furthermore, a superposition of H. pylori CeuE structure with the 
BtuF VitB12-receptor, whose structure has been solved in complex with the other 
members of the transporter, BtuC/D, allowed to confirm that CeuE shares two 
conserved and surface exposed glutamic residues that are properly oriented on the 
protein surface to interact with two positively charged residues on the periplasmic 
surface of the transmembrane partner, elements that play a key role in the metal 
delivery mechanism.  
It has been postulated that H. pylori uses the ExbB/EsbD/TonB transport system to 
import nickel complexed by an unknown nickelophore captured from the 
environment (Schauer et al., 2007). In this paper we have demonstrated that H. 
pylori CeuE selectively binds Ni2+ in vitro thanks to a two-histidine complex. We have 
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not demonstrated the exact nature of this ligand in vivo, nevertheless the 
observation that CeuE binds Ni(L-His)2 in a way similar to E. coli NikA, despite the 
two proteins belong to different families, strongly suggests a more general 
physiological function for this nickel complex. 
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Introduction  
 
H. pylori flagellar biosynthesis is tightly coordinated by the activities of σ54 (HP0714) 
and σ28 (HP1032) factors that mediate the flagellar genes expression. Flagellar 
proteins turnover is phase-variable and regulated by a posttranslational mechanisms 
(Lertsethtakarn P, 2011). The mature flagellum is composed by a hook – basal boy 
complex and the extracellular filament. In the first complex, the inner membrane 
base (MS ring base, flagellar type III secretion system, cytoplasmic C ring, the motor) 
is localized in the cytoplasm, whilst in the periplasm there is the rod (with P ring and 
L ring) and the hook is extracellular.  
The hook components are secreted when the periplasmic rod is completed. To 
determine the correct Helicobacter pylori hook length, FlgD and FliK mediate the 
assembly of FlgE monomers. Therefore, FlgD plays a critical role during the assembly 
of flagellar hook (Zhou H, 2011). Immunoelectron microscopy technique has been 
used to localize FlgD at the distal end of the rod and at the distal end of the hook, 
acting as a hook capping protein (Ohnishi K, 1994).  Hence, it is involved when the 
rod is completed and discarded when the hook has reached its mature length. The 
interaction with the hook junction proteins (FlgK and FlgL) blocks the hook 
maturation and permits the formation of the filament with the filament capping 
protein, FliD (Homma M, 1986).  FlgD has been classified as a member of axial family 
of exported flagellar proteins. Studies on Escherichia coli and Salmonella enterica 
flagellar biosynthesis suggest that FlgD regulates the flagellar hook assembly owing 
to transient intermediate structure. In fact, FlgD has not been detected in mature 
flagella (Pallen MJ, 2005). FlgD regulates the hook monomer polymerization, 
preventing the leakage of hook monomers and controls the correct hook length.  
Xantomonas campestris C-term FlgD (Kuo WT, 2008) and Pseudomonas aeruginosa 
FlgD molecular structure (Zhou H, 2011) have been determined at 2.5Å and 2.5Å 
resolution, respectively. A novel hybrid comprising Tudor-like domain interdigitated 
with a fibronectin type III domain has been revealed.  
In our study H. pylori FlgD was cloned, expressed and purified. Oligomerization state 
and secondary structure components have been experimentally defined. FlgD 
crystals diffracted to 2.7Å of resolution. The crystal structure has not been solved 
yet. Low sequence similarity of HpFlgD with XcFlgD and PaFlgD revealed that 
possible different molecular structure could be present in Helicobacter pylori hook 
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scaffolding protein FlgD.  
 
Materials and Methods 
Molecular Cloning 
H. pylori flgD is located in genome locus C694_0467 (EMBL AFV42119.1). The 
corresponding nucleotide sequence (HP0858) has been amplified by PCR using a 
thermostable Phusion high-fidelity taq polymerase (NEB) starting from the purified 
genomic DNA of H. pylori G27 strain. FlgD has been cloned into the pETite (Lucigen) 
plasmid vector in frame with a C-terminal His-tag, using 5’ primer - GGA GAT ATA 
CAT ATG GCT ATT GAT TTA GCA GAA G – (forward) and 3’ - GTG ATG GTG GTG ATG 
ATG TGC TGT CTC TTT AGG GG –(reverse). The amplified 
gene has been cloned in pETite (Lucigen) pre-processed 
linearized free-enzyme plasmid vector, in frame to a C-
term His-tag. The cloning has been performed by thermal 
shock transformation of E. coli G10 strain (Lucigen), 
grown over night on LB medium supplemented of 
Kanamycin (30µg/ml). The colonies were controlled by 
colony-PCR using combined primers FlgD forward and T7 
reverse primers and vice versa. Purified plasmid of 
positive colonies have been  
 examined with double digestion restriction enzymes (NdeI and 
NotI) for 2 hours at 37°C, than inactivated for 20 minutes 
at 65°C.  Positive samples have been sequenced by 
BMR™ sequencing services with T7 forward and reverse 
primers. 
 
Overexpression and purification 
pETite-FlgD plasmid has been used to transform E. coli BL21 (DE3) strain. Protein 
expression has been performed for 4 hours at 28°C in Luria Bertani medium 
containing kanamycin resistance at 30 µg/ml, after induction with isopropyl-β-1-
thiogalactopyranoside (Sigma). The biomass has been separated from medium by 
centrifugation for 15 minutes at 11000g, re-suspended in lysis buffer (Tris 20mM pH 
A             B 
 
Figure 3.1- (A) SDS PAGE FlgD, 
Molecular weight marker 
(116, 66, 45, 30, 20, 18, 14 
kDa ), B) SeMet FlgD. 
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7.5, NaCl 150mM, PMSF 2mM) and disrupted with One Shot Cell breakage system 
(Constant System Ltd., UK). The lysate has been clarified by centrifugation at 40000g 
for 30 minutes and supernatant was loaded on a 5-ml His-trap column (GE 
Healthcare) equilibrated with the buffer. After washing step with buffer 
supplemented with 20mM imidazole, the protein has been eluted in imidazole 
gradient to 500mM. The protein has been loaded on a Superdex 200 16/60 GL 
preparative gel filtration chromatography column (GE Healthcare).  The eluted 
protein was concentrate by ultrafiltration (Vivaspin 10000MW 15R, Sartorius) to 
30g/l for crystallization purposes. The protein concentration has been determined 
by UV/Vis spectroscopy (280nm, Cary 50 Bio UV-Visible spectrophotometer, Varian 
Inc.) using theoretical absorption coefficient. Protein purity has been checked by 
SDS-PAGE at the end of the purification step and loaded at different concentrations 
(Figure 3.1 A).  
Expression of recombinant seleno-methionine derived FlgD (Figure 3.1 B) has been 
performed using a Met auxotroph E. coli strain (B834). The bacteria were grown in 1 
liter of minimal medium M9 supplemented of 2% glucose, vitamin B1, amino acids 
and seleno-methionine. The purification step was the same as described before.   
Circular Dichroism (CD) 
To detect secondary structure components of FlgD, a Circular Dichroism analysis has 
been performed. The instrument used was a JASCO J-715 Spectropolarimeter 
operated at 298K. 5 runs have been  
 accumulated with 0.14 g/l (Tris 
20mM pH7.5, NaCl 150mM) in a 
0.05 cm path length cell, in the 
wavelength interval 190-260 nm 
(Figure 3.2). Molar ellipticity was 
estimated by the buffer spectrum, 
rescaled to a standard solution 
containing the buffer. The 
secondary structure was predicted 
by deconvolution performed with 
the software “CD Spectra 
Deconvolution” (CDNN 2.1). 
 
Figure 3.2 – Recombinant purified FlgD Circular 
Dichroism 
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 Analytical Gel Filtration 
FlgD mass has been estimated by analytical gel filtration chromatography using 
Superose 12 10/300 GL (GE Healthcare), equilibrated with Tris 20mM pH 7.5, NaCl 
150mM, with AKTA FPLC instrument (GE Healthcare). Recombinant His tagged FlgD 
was eluted in a single peak with a retention time of 11.28 ml (Figure 3.3).  The 
molecular mass calculated from analytical gel filtration chromatography analysis was 
about 141,000 Da. Considering FlgD monomer as His tag fusion protein (2.7 kDa), its 
molecular mass resulted to be 35468 Da. Therefore, FlgD oligomerization state 
resulted to be tetrameric in solution. 
 
Figure 3.3 – Recombinant purified FlgD analytical gel filtration chromatography Superose 12™ 10/300 
GL 
 
Dynamic Light Scattering 
Recombinant FlgD has been analyzed with Dynamic Light Scattering instrument at 
DLS Zetasizer Nano ZS (Malven Instruments). FlgD concentration was determined to 
be 2.23 g/l. The analysis was performed at 25°C with a temperature equilibration 
time of 120 sec. The viscosity of the bulk material was of 0.8872 cP. A low volume 
quartz batch cuvette QS 3.00 mm (Malvern) was used. The measure of Z-Average 
size (± SD)(d.nm) resulted to be 14,22 ± 8.985 with a polydispersity index of 0.399 
(Figure 3.4). The hydrodynamic radius of predominant particle was 10.10 nm ± 3.214 
(SD) and estimation of molecular weight was 148,8 kDa ± 51.4 (SD). In the graph the 
sample distribution of molecular mass (size nm) versus volume (percentage) has 
been reported.  The mass estimated with DLS indicates that the oligomerization 
state of FlgD is tetrameric.  
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Figure 3.4. Recombinant purified FlgD Dynamic Light Scattering analysis 
 
Crystallization and X-ray diffraction analysis 
Recombinant FlgD has been concentrated to 30 g/l and different crystallization kits 
have been tested. The crystallization plates have been prepared with the partially 
automated “Oryx Crystallization robot” (Douglas Instruments, UK). The best crystals 
have been obtained with vapor diffusion technique, at 293 K (Figure 3.5). The 
precipitant solution correspond to the position A4 (number 4) of PACT suite 
(Molecular Dimension) containing 0.1M SPG pH 7.0, 25% PEG1500. Other crystals 
have been obtained with precipitant solution 32 of PEGSII (0.2M NaAcetate, 0.1M 
Tris pH 8.5, 16% PEG4000) and with solution 80 of PEGS II (0.01M TriSodiumCirate, 
16% PEG6000).  
Diffraction data have been measured at the ID14-4 beam line of European 
Synchrotron Radiation Facility of Grenoble, France. One crystal was used to measure 
an entire data set. The data have been indexed and integrated with Mosflm 
software (Leslie AG, 2006), merged and scaled with Scala (Evans P, 2006), contained 
in the CCP4 crystallography package (CCP4, 1994). The crystal belongs to the 
monoclinic space group P2 or P21 with cell parameters  a= 77.25 Å, b=34.15 Å, 
c=131.45 Å, β=99.6°. The Rmerge for all data is 0.073 and the best resolution is 2.75 Å. 
Statistics on data collection are reported in Table 3.1. Molecular replacement was 
tried with program Molrep (Vagin AA, 1997). 
 
 
A B 
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Figure 3.5 (A) FlgD crystal mounted at beam line 14 of ESRF of Grenoble, France. (B) 
FlgD crystal diffraction pattern. 
 
Data FlgD 
Wavelength 0.95372 
Space group P2 
a, b, c (Å), β(°) Z a= 77.25, b=34.15, c=131.45, β=99.6 
Z=2 
Resolution (Å) 54.09 - 2.75 (2.90-2.75) 
R
merge
 0.073 (0.503) 
Rpim 0.045 (0.313) 
Unique reflections 18367 (2641) 
<I /σ(I)> 11.1 (2.5) 
Completeness (%) 99.9 (99.5) 
Multipliciy 3.6 (3.5) 
 
Table 3.1 FlgD crystal data  
 
Bioinformatics analysis 
The homology modeling has been performed with secondary sequence predictors 
and molecular model servers. Proteomic website Expasy (www.expasy.org/toos) 
servers, Jpred (Cole C., 2008), and PSIpred (Buchan D.W.A., 2013) have been used to 
generate a two-dimensional secondary structure consensus for each residue (Figure 
3.6). For molecular modeling SWISS MODEL (Arnold K., 2006), Phyre server (Kelly LA, 
2009) and E-Tasser (Zhang Y, 2008) have been used.  
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Figure 3.6. FlgD homology model generated by Pyre server (Model n.1).  
Results and Discussion 
In this thesis, Helicobacter pylori FlgD has been investigated. It has been cloned and 
expressed in E. coli. FlgD is classified as a flagellar secreted protein, but no secretion 
signal has been detected in the sequence analysis (Signal P 2.0 Server). It is 
annotated as a flagellar basal body modification protein.  
The protein expressed in E. coli resulted to be cytosolic and soluble. The predicted 
molecular weight of the monomer (Protparam, Walker JM, 2005) with the His tag 
(2.7 kDa) resulted to be 35,486 Da. This value was confirmed by the migration of 
purified FlgD in SDS-PAGE gel, which corresponds to the band of the marker at 35 
kDa (Low Molecular Weight, NEB™) (Figure 3.7 A). Recombinant FlgD presented a 
strong degradation, reduced by the addition during purification of protease 
inhibitors (PMSF 2mM). Part of FlgD degradation was also removed by preparative 
gel-filtration chromatography (Figure 3.7 B).  
 
 
 
Figure – Recombinant FlgD preparative gel filtration chromatography Superdex 200™ 
16/60 GL  – SDS PAGE  FlgD fraction of gel filtration. 
 
It was possible to purify 10 g/L of nearly pure soluble protein. Analytical gel filtration, 
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confirmed by dynamic light scattering measurements, suggested a tetrameric 
oligomerization state for FlgD in solution. Dynamic light scattering measurements presented 
a predominant particle of FlgD with a diameter of about 10.1 nm, compatible with four-time 
the molecular weight of the FlgD monomer. The other two FlgD structures known,  XcFlgD 
and PaFlgD are dimers in solution as well as in asymmetric unit in the crystal, however a 
possible tetrameric oligomerization state has been suggested in physiological conditions. 
The protein was concentrated to 30g/l and different crystallization screening kits have been 
tested. Crystals were grown after months of incubation with a solution containing 0.1M SPG 
pH 7.0 and 25% PEG1500. The crystals tested diffract at a maximum resolution of 2.7Å.  
The crystal structure of Pseudomonas aeruginosa FlgD and that of Xanthomonas campestris 
C-terminal FlgD domain have been published. The sequence similarity among these two 
species and H. pylori FlgD is lower than 10%, with only 35 identical positions conserved in 
the amino acid sequence. It has not been possible, using the FlgD molecular structures 
already determined, to solve the structure of H. pylori FlgD by molecular replacement. 
Moreover, different possible molecular models have been generated, despite the low 
sequence similarity. The initial model obtained with the SWISS MODEL PDB Server covered 
residues from 165 to 251 of H. pylori FlgD, which is composed of 316 amino acids. The 
similarity in the domain is 18%. Moreover, molecular models have been optimized with a 
homology modelling approach.  
A secondary structure prediction consensus has been generated using Jpred and PSIpred. 
The amounts of secondary structure components of this prediction have been checked 
through secondary structure prediction and circular dichroism. Several molecular models 
were generated with E-Tasser and Phyre servers and the ones that present the correct 
amount of secondary structure have been used for molecular replacement. Despite these 
efforts, all molecular replacement attempts failed to find a correct solution.  
Meanwhile, the recombinant seleno-methionine containing FlgD was expressed and 
purified, but no protein crystals have been grown till now.  
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Abstract 
 
H. pylori is the only bacterium discovered able to survive in the hostile 
environment of human gastric mucosa and establish chronic colonization. The 
presence of virulence factors often represents the discriminant among 
pathogenic and not pathogenic strains. The former are associated to severe 
diseases, such as gastritis and cancer.  A preliminary study has been performed 
on different proteins involved in two important colonization factors, the 
bacterial flagellum and the heat-shock proteins involved in cellular stress 
response. In particular, from the flagellar apparatus the C-ring flagellar switch 
protein FliN, the HAPs proteins (FlgL - FlgK - FliD) with their specific substrate 
chaperone FlgN and FliT have been investigated. Among the heat shock 
proteins analyzed, there are the two transcription regulators HspR and HrcA 
and the associated protein Orf (HP1026), the latter of unknown function. 
These proteins have been cloned in a plasmid vector to be expressed in E. coli. 
A molecular characterization has been performed on successfully purified 
proteins using analytical gel filtration chromatography, dynamic light scattering 
and circular dichroism, defining the oligomerization state in solution and the 
secondary structure content.   
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INTRODUCTION 
FLAGELLINS 
H. pylori is a polar flagellate bacterium. To colonize human gastric mucosa, it has evolved 
different virulence determinants that are necessary for pathogenesis. Less motile strains are less 
able to survive in the hostile environment of the human stomach than fully motile strains. 
Therefore, H. pylori motility is considered one of the most important colonization factors 
(O’Toolle PW, 2000). Complementary studies on Helicobacter mustelae suggest that motility 
plays a key role in the initial colonization for a long-term persistence (Andrutis KA, 1997). 
Cytokine response has been associated to H. pylori motility, in particular IL-8 induction 
(Watanabe S, 1997), demonstrating that the stage of gastric disease contributes to the 
maintenance of high motility. H. pylori does not present genetic cluster organization of flagellar 
genes. Gene expression is regulated by σ factors. Nine operons containing 15 flagellar genes 
characterized by σ70 consensus sequence and five operons containing hook basal body genes 
recognized by σ54 promoter region have been identified (Spohn G, 1999).   
The structural organization of the H. pylori flagellum can be divided in three components: i) the 
basal body, which includes the rings, the motor, the switch proteins and the type III secretion 
system proteins; ii) the hook, a flexible structure that links the filament to drive in the basal body 
(Macnab RM, 1996); iii) the extracellular filament masked by a sheath whose ultrastructure 
features are relatively uncommon (Goodwin CS, 1985). The sheath contains also phospholipids 
and LPS similarly to the outer membrane, but with different proteins and fatty acids amount 
(Geis G, 1993). The possible roles of this sheath are the acid protection, masking of flagellar 
antigen and cellular adhesion (Jones AC, 1997).  
The flagellar proteins secretion system and flagellar switch are regulated by the cytoplasmic C 
ring. This intracellular complex is composed of FliG, FliM and FliN (Lowenthal AC, 2009). FliG is 
involved in the turning of clockwise or counterclockwise rotation, modifying flagellar switch. 
CheY is a chemotaxis response regulator (Sarkar MK, 2010) that binds FliM or FliN. When CheY is 
phosphorylated, a clockwise rotation of H. pylori flagellum is observed, and vice versa. 
Moreover, FliN interacts with protein complexes belonging to the type III secretion system 
components, such as FliH, FliI or with substrate chaperone partners (Thomas J, 2004).  
A flagellum-specific secretion pathway exports, through a central channel, the proteins involved 
in the basal body rod formation, the hook, the hook filament junction and the filament with its 
cap (Homma 1990). These proteins have been observed to polymerize in order to form the 
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hollow filamentous axial structure. The expression of flagellar axial substructure is sequential to 
that of the previous components (Kubori T, 1992), except for the assembly of the filament cap 
that starts upon the completion of the FlgK-FlgL hook filament junction, to allow the 
polymerization of the filament (Homma M, 1984). When the hook is completed, FlgK and FlgL, 
two hook-junction proteins, bind FliD, the filament capping protein, which mediates the filament 
assembly. The reason why these three proteins have been classified as HAPs (Hook associated 
proteins) derives by their simultaneous presence, when the hook is completed. Specific 
interactions with HAPs have been observed by putative export chaperones that facilitate the 
initiation of filament assembly (Kutsukake K, 1994). In particular, FlgN shows a specific affinity 
for FlgK and FlgL, and FliT for FliD, preventing cytosolic axial polymerization (Fraser GM, 1999). 
Co-expression experiments have been planned in order to increase recombinant protein 
solubility expressed in heterologous system. The aim of our study was to determine the 
molecular structure of FliD-FliT and FlgKL-FlgN complexes and to define their interaction 
domains using the X-ray single crystal diffraction technique.  
 
Heat Shock Proteins 
Heat-shock proteins (Hsps) are produced when bacteria encounter stress such as elevated 
temperatures, but also ethanol, H2O2 and acid. Hsps such as DnaK and GroEL promote the 
proper folding and increase the survival of the pathogens in harsh environments (Craig, 1993). It 
was demonstrated that H. pylori Hsps play an important role during the host infection (Hoffman, 
2003). In fact GroEL and GroES H. pylori homologue not only assist the proper protein folding, 
but also are considered an important modulator of urease enzyme activity (Dunn, 2007; Evans, 
1992; Kansau, 1996).  
Response to stress is a tool conserved through both eukaryotes and prokaryotes, but the 
molecular mechanisms between the two species are different. In E. coli and most of other gram-
negative bacteria there is a positive regulation governed by a specific sigma factor (σ32), which 
induce the transcription of heat shock genes under stress condition (Bukau, 1993). Negative 
regulation is also common in Bacillus subtilis and other gram-negative and gram-positive 
bacteria, where there is the involvement of a transcriptional repressor, HrcA, which binds a 
CIRCE DNA region. This transcriptional regulator binds DNA in the promoter region of heat shock 
genes under non-stressed conditions, inactivating the relative genes (Shulz, 1996; Zuber, 1994).  
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Another negative mechanism of transcription repression involves HspR, which directly controls 
the transcription of dnaK operon in Streptomyces, binding in the promoter region to three 
partially related inverted repeats of DNA, known as HAIR (HspR as associated inverted repeats) 
(Bucca, 1995). Moreover, HspR is able to auto regulate its own synthesis by repressing the 
promoter responsible for the transcription of the DNA region that contains the hspR gene itself, 
H. pylori DnaJ homologue, and a third gene named orf, of unknown function. Therefore, HspR 
negatively regulates groELS operon and hrcA-grpE-dnaK operon, which are also regulated by 
HrcA. This was demonstrated by hrcA deletion, as well as hspR and hrcA/hspR deletions. In non-
stress condition, both HspR and HrcA are necessary in order to leave Pgro and Phrc repressed 
(Spohn, 2004). HspR binds the operon located far upstream from the promoters (Spohn, 1999), 
while the DNA binding site of HrcA is closer to the transcription starting point. Recently, another 
mechanism of HspR and HrcA on H. pylori genome regulation has been demonstrated. In fact, 
the genes regulated by HspR and HrcA are 43: not all are repressors, but they also activate the 
transcription of 14 genes involved in the biosynthesis and assembly of the flagellar apparatus 
(Roncarati, 2006). The motility of H. pylori has been associated to heat shock proteins expression 
(Colland, 2001; Niheus, 2004), as well as in C. jejuni (Andersen, 2005).  
In silico sequence analysis predicts that HrcA presents a trans-membrane domain from residue 
146 to 156, suggesting a similarity to the membrane-bound activator ToxR of Vibro cholerae, 
which regulates virulence gene expression by sensing environmental stimuli of periplasmic 
domain and transmitting them directly to its cytoplasmic DNA-binding domain (Kurukonis, 2000; 
Skorupski, 1997). HrcA activity depends by the presence of HspR, because it has been 
demonstrated that HrcA is not able to bind DNA in absence of HspR (Spohn, 2004).  
HspR presents an oligomerization domain composed by hepta-repeats of hydrophobic residues, 
also present in eukaryotic heat shock transcription factors. These repeats could mediate 
trimerization, forming a coiled-coil structure between monomers (Narberhaus, 1999; Sorger, 
1989).  
The sequence similarity between H. pylori HrcA and structurally solved T. marittima is around 
30% (Liu J, 2005).  T. marittima HrcA crystallizes as a dimer. The structure was determined at 
2.2Å resolution and the monomer is composed by three domains: a helix-turn-helix N-terminal 
domain (WH), a GAF like domain, and an inserted dimerization domain (IDD). The IDD, even if 
composed by hydrophobic residues, presents a unique structural fold with an anti-parallel β-
sheet made by three β-strands sided by four α-helices. 
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Orf (HP1026) is the third gene present in the cbpA-hspR-hp1026 multicistronic operon. The heat 
shock response of H. pylori is regulated by groESL, hrcA-grpE-dnaK, and cbpA-hspr-orf operons. 
They are negatively regulated by HspR. The structural and functional role of Orf is still unclear. 
Sequence analysis of Orf identifies a possible helicase domain, coupled to an ATP binding site 
(unpublished data, V. Scarlato and Alberto Danielli, Department of Biology, Bologna University). 
H. pylori Orf knockout does not present growth defects, but preliminary results show a lower 
capacity of the mutant to return to the basal expression level of the heat shock genes induced 
after shock with respect to wild type strains.       
The proteins described have been cloned, successfully expressed and purified. In vitro 
characterization has been performed using circular dichoism, analytical gel filtration 
chromatography and dynamic light scattering techniques. 
 
Material and Methods 
Molecular cloning and mutagenesis 
FliN (HP0584), FliT (HP0754), FlgN (HP1457) nucleotide sequences have been amplified from G27 
H. pylori strain using forward (‘5’-‘3’) and reverse (‘3’-‘5’) primers reported in table (4.1). FlgN 
was amplified from residue 29 to residue 210. The amplified DNA fragments have been 
separated in agarose gel (1%) and DNA was extracted with Gel Extraction kit (Qiagen).  The 
purified DNA was cloned in the C-term His-tag pETite plasmid vector (Lucigen) and positive 
colonies have been controlled by colony PCR. Extracted plasmids (MiniPrep kit Sigma) have been 
controlled with restriction enzyme double digestion (NdeI and NotI, NEB) and plasmid 
sequencing (BMR genomics sequencing service).  
FliD (HP0752), FlgK (HP1119), FlgL (HP0295) genomic sequences have been amplified from G27 
H. pylori strain. Molecular primers have been designed in frame to a N-term strep tag sequence 
(WSHPQFEK) insertion and cleavage site for restriction enzyme in 5’ and 3’ (Table 4.1). DNA 
amplified fragments have been cloned in Zero Blunt® TOPO PCR cloning kit (Invitrogen) plasmid 
vector. The cloning has been verified with enzymatic digestion and plasmid sequencing (BMR 
genomics sequencing service). 
HspR, HrcA and Orf have been cloned in collaboration with A. Danielli and V. Scarlato, Dept. of 
Biology, Bologna, Italy. HspR (HP1025) nucleotide sequence has been amplified from 26695 H. 
pylori strain and cloned in pET22b(+) plasmid vector (Novagen). HspR mutagenesis has been 
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performed using ‘5’ – ‘3’ primer HspRC2Y_fw GAT ATA CAT AAT ATC ATA TGT ACG ATT ATG ATG 
AAC CGC TTT A and HspRC2Y_rev TAA AGC GGT TCA TCA TAA TCG TAC ATA TGA TAT TAT GTA 
TAT C. HrcA (HP0111) has been synthetized as optimized gene from Gene Optimizer Assisted 
(Life technologies) and cloned in pET22b(+) (Novagen) plasmid vector. Orf (HP1026) has been 
amplified from 26695 H. pylori strain and cloned in pET22b(+) (Novagen).  
Name Sequence Restriction 
site 
FliN_G27_fw GGA GAT ATA CAT ATG CCA GAA ACA GAA GCT AAT AAG  
FliN_G27_rev GTG ATG GTG GTG ATG ATG TGA ATT TTT AGC GAG ATA ATA C  
FliT_G27_fw GAA GGA GAT ATA CAT ATG TTGATAGAGCGCCTTTCTTTAGAGC  
FliT_G27_rev GTG ATG GTG GTG ATG ATG AGACAAAAATTTTTGAATCTTTTTAG  
FlgN_G27_fw GAA GGA GAT ATA CAT ATG ACT TAT CAA AAT GTG AAT GAT G  
FlgN_G27_rv GTG ATG GTG GTG ATG ATG AAACATACGCTTATTGCTAGC  
FliD_G27_fw GGA TCC ATG GCT AGC TGG AGC CAC CCG CAG TTC GAA AAA GGC GCC 
GCA ATA GGT TCA TTA AGC 
BamHI  
FliD_G27_rev CTC GAG TTA ATT CTT TTT AGC CGC CGC TTG XhoI  
FlgK_G27_fw  GGA TCC ATG GCT AGC TGG AGC CAC CCG CAG TTC GAA AAA GGC GCC 
GGC GGA ATC TTA TCT TCA CTC 
BamHI  
FlgK_G27_rev CTC GAG TTA TTG TTT AAT CCC CAA TAA AGT GTC XhoI  
FlgL_G27_fw GGA TCC ATG GCT AGC TGG AGC CAC CCG CAG TTC GAA AAA GGC GCC 
CGC GTT ACC TTT GGC TC 
BamHI  
FlgL_G27_rev  CTC GAG CTA CAA ATA TTT CGT TAA AGA C XhoI  
Table 4.1 Oligonucleotide design for target gene amplification  
Bioinformatics 
The Signal P 4.1 Server (Petersen T N, 2011) has been used to predict the presence of a signal 
secretion peptide in an in silico analysis of protein sequence using a combination of neural 
networks. Gram-negative prokaryotes organism, cleavage site and signal peptide prediction have 
been selected. From FlgN amino acids sequence analysis, a cleavage site between position 28 
and 29 with a probability of 60% has been predicted. 
 
Figure 4.1 FlgN signal peptide prediction made with Signal P 4.1 Server 
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Overexpression, purification and crystallization trials  
Transformation of C-term pETite-FliN and pETite-FliT have been performed in E. coli BL21 (DE3). 
Bacteria were grown in 2 Liter Luria Bertani medium supplemented of 30µg/ml kanamycin, at 
37°C until reach 0.4 OD600. The expression has been inducted with 0.5 mM IPTG (isopropyl-β-1-
thiogalactopyranoside, Sigma) and the bacteria have been lied to 28°C for 5 hours under hard 
shaking.  The bacteria have been separated from medium by centrifugation (15 minutes at 
11000g), resuspended in LB medium and then disrupted by a One Shot Cell breakage system at 
1.35psi (Constant System Ltd., UK). The lysates have been centrifuged for 20 minutes at 10,000g. 
Insoluble fractions have been washed with TBS buffer supplemented by EDTA 0.5 mM, Urea 
0.1M and Triton X1000 2% and then centrifuged again. 18 hours denaturation step in hard 
shaking have been performed in Tris-HCl 20 mM, Urea 8M, pH 8.0. The solutions have been 
centrifuged and loaded in a Ni-IMAC column pre-equilibrated with denaturant buffer. Before the 
elution (TrisHCl 20 mM, NaCl 100 mM, Imidazole 300 mM), different washing steps have been 
performed with the supplement of Imidazole (20 mM), β-mercaptoethanol (2 mM), Triton X100 
(0.1 %) and β-ciclodextrin (5 mM). FliN and FliT have been eluted in a single step of elution at 
300 mM Imidazole. A PD-10 Desalting column (Sigma), equilibrated with Tris 20 mM NaCl 100 
mM buffer, has been used to remove Imidazole from the protein solution.   
Recombinant FlgN expression has been performed in E. coli BL21 (DE3) for 4 hours alter 
induction (0.5 mM IPTG) in reach medium supplemented of antibiotic (kanamycin 30µg/ml). The 
bacteria was collected, disrupted with mechanical system (One Shot Cell breakage system, 
Constant System Ltd., UK) and clarified by centrifugation (30 minutes at 18,000g). Recombinant 
FlgN has been purified from the soluble fraction, loading the supernatant on a column 
containing 5ml of Ni2+ charged Chelating Sepharose™ (GE Healthcare). The extensive washing 
was performed with NaH2PO4, 20 mM NaCl, 300 mM and Imidazole 20 mM. The protein was 
eluted in a linear gradient from 20 to 500 mM Imidazole. Preparative Superdex 200™ (16/60) has 
been used to filter the purified protein.  
 
 
73 
 
 
Figure 4.2 Recombinant FlgN preparative gel filtration, Superdex 200   
 
HspR has been expressed in E. Coli Arctic (DE3) in 2 liters of LB medium at 37°C until optical 
density (OD600) 0.6 and then induced with 0.5 mM IPTG overnight at 16°C. The bacteria have 
been collected and resuspended in lysis buffer (NaH2PO4 50 mM, NaCl 300 mM) supplemented 
of 1mg/ml DNAse (Sigma), 1mg/ml ribonuclease (Sigma), 0.01% NP-40 (Tergitol), 0.2 mM PMSF. 
The lysis has been performed with a French press (One Shot Cell breakage system, Constant 
System Ltd., UK) at 1.4 psi and clarified by centrifugation for 30 minutes at 18,000g. The soluble 
fraction has been loaded in a 1ml Ni2+ charged Sepharose™ column (GE Healthcare). After 
extensive wash with buffer supplemented of 20 mM Imidazole, the protein has been eluted in a 
linear gradient from 20 to 500 mM imidazole. Preparative gel filtration (Superdex 75 16/60 GL) 
has been performed to purify the protein and to remove imidazole from the solution.  
A PD -10 desalting column has been used to change the buffer into a solution of HEPES 20 mM 
pH 7.5, NaCl 200 mM, supplemented of EDTA (2 mM), DTT (5 mM).  
Recombinant HrcA has been expressed in E. coli Arctic (DE3) strain. The bacteria were grown at 
28°C in Luria Bertani medium supplemented of Ampicillin (100 µg/ml) until 0.5 optical density 
(OD600) was reached, were induced with IPTG (0.5 mM) and the expression last 18h at 12°C. After 
centrifugation, lysis was performed using a French press system (1.4 psi) in buffer (NaH2PO4 50 
mM, NaCl 300 mM) supplemented of 1mg/ml DNAse (Sigma), 1mg/ml ribonuclease (Sigma), 
0.01% NP-40 (Tergitol), 0.2 mM PMSF. Clarification has been performed by centrifugation at 
18,000 g for 30 minutes and the soluble fraction loaded in a Ni2+ charged Sepharose™ column 
(GE Healthcare). Addition of 20 mM imidazole to the buffer solution has been used to wash the 
column and the HrcA has been eluted in a linear gradient from 20 to 300 mM Imidazole. HrcA 
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has been treated with a PD-10 Desalting column (Sigma), equilibrated with Tris 20 mM NaCl 300 
mM buffer, to remove imidazole from the protein solution.   
Orf has been expressed in E. coli BL21 (DE3) for 4 hours after induction (0.5 mM IPTG) in reach 
medium supplemented of 50µg/ml ampicillin. Bacteria were collected, re-suspended (Tris 20 
mM pH 7.5, NaCl 150 mM), lysed (One Shot Cell breakage system, Constant System Ltd., UK) and 
clarified by centrifugation (30 minutes at 18,000g). Supernatant has been loaded on a 5ml Ni2+ 
charged Chelating Sepharose™ column (GE Healthcare). After extensive washing with imidazole 
20 mM added to the buffer, the protein was eluted in a linear gradient from 20 to 300 mM 
Imidazole. Preparative Superdex 200™ (16/60) has been used to filter purified protein.  
The molecular weight of recombinant proteins has been estimated by 15% sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and stained with 0.25% Coomassie 
Brilliant Blue R250 reagent.  
UV/Vis spectroscopy, (280nm, Cary 50 Bio UV-Visible spectrophotometer, Varian Inc.) was used 
to determine protein concentration, using theoretical absorption coefficient.  
For crystallization purposes, purified recombinant proteins have been concentrated at least to 
10g/l using  ultrafiltration (Vivaspin 5,000 and 10,000 MW, 15R).   
Semi-automated Oryx 8 crystallization robot (Douglas Instruments) has been used to prepare 
different crystallization kits of Hampton (Crystal Screen I and II) and Molecular Dimension 
(Structure Screen I and II, PACT suite, PEGsII, PGA, JCSG I-IV, AmSO4) at 293 K with sitting drop 
vapor diffusion technique. 
Solubility analysis 
Refolding tests screening have been performed on inclusion bodies of HrcA. The bacteria (E. coli 
Arctic strain) that have expressed recombinant HrcA have been resuspended in TBS buffer (8 ml) 
in the ratio 20 ml of buffer to 1L of culture. The bacteria have been lysed with French press (One 
Shot Cell breakage system, Constant System Ltd., UK) at 1.4 psi. The lysate has been divided in 4 
aliquots and centrifuged for 15 minutes at 18,000g. The soluble fractions have been separated 
from the pellets that have been gently equilibrated with detergents for 4 hours at 4°C. The 
detergents that have been used were C12E8 (2.5% w/v), Deossicolate (2.5% w/v) and NP-40 (2.5% 
w/v). Buffer without detergent has been used as control. The mixtures have been centrifuged 
(15 minutes at 18,000 g) and the proteins solubility analyzed by 15% sodium SDS–polyacrylamide 
gel electrophoresis, stained with 0.25% Coomassie Brilliant Blue R250 reagent. 
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Figure 4.3 SDS-PAGE HrcA solubility test. LMW (97, 66, 45, 30, 
20, 14 kDa), (Supernatant/Pellet) Negative Control, (S/P) C12E8 
2.5% w/v, (S/P) Deossicolate 2.5% w/v and (S/P) NP-40 2.5% 
w/v. 
Circular Dichroism 
Circular Dichoism analysis was performed on FlgN, FliT, HrcA and Orf to identify the secondary 
structure components. The instrument used was JASCO J-715 Spectropolarimeter at 298K.  It has 
been accumulated 5 runs with  (Tris 20 mM pH7.5, NaCl 150 mM) in a 0.05 cm path length cell. 
The wavelength interval analyzed was 190-260 nm. A solution containing the buffer was used for 
data rescaling and for estimating  molar ellipticity. The deconvolution has been performed with 
the software “CD Spectra Deconvolution” (CDNN 2.1). 
A  B  
C  D 
190-260 nm FliT FlgN Orf 
α-helix 16.4% 21.7% 34.8% 
β- sheet 44.1% 27.8% 15.5% 
β – turn 15.8% 22.3% 16.6% 
Random coil 27.3% 32.3% 31.3% 
Total 103.7% 104% 98.4% 
Figure 4.4 Circular Dichroism of recombinant purified FliT (A), FlgN (B), ORF (C). D) Table 4.2 Secondary 
structure amounts of CD spectra deconvolution with CDNN2.1 
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 Analytical Gel Filtration 
Molecular mass and oligomerization state were estimated by analytical gel filtration using 
Superose 12 16/60 GL (GE Healthcare™), equilibrated with Tris 20 mM pH 7.5, NaCl 150 mM, 
with AKTA FPLC instrument (GE Healthcare™). The calibration curve has been performed with 
Cytochrome C (12.4 kDa), Alcohol Dehydrogenase (29 kDa), Albumin (66 kDa), Carbonic anidrase 
(150 kDa), β-amiloidase (200 kDa) and Blue dextran (2000). His tag FliN and FliT were eluted as 
one single distribution peak. FlgN eluted in a single peak with a retention time of 12 ml with 
molecular mass, estimated by analytical gel filtration analysis, of 20.06 kDa. The theoretical 
molecular mass of the FlgN monomer with His tag  (2.7 kDa) is 21.1 kDa. The retention time of 
Orf in analytical gel filtration analysis with Superose 12™ was 11.44 ml, corresponding to a 
molecular mass of 125.9 kDa. Its monomer with His tag has been calculated to be 43.8 kDa. 
A
 
B
 
Figure 4.5 Analytical Gel filtration Superose 12 16/60 of purified FlgN (A) and ORF (B) 
 
Dynamic Light Scattering 
Recombinant FlgN, FliN, FliT, HrcA and Orf  have been analyzed with Dynamic Light Scattering 
instrument at DLS Zetasizer Nano ZS (Malven Instruments) using crystallization condition. The 
analysis was performed at 25°C with a temperature equilibration time of 60 sec. The viscosity of 
the bulk material was of 0.8872 cP. The cuvette used was a Low Volume Gas Cuvette (Malvern). 
The measure of Z-Average size (± SD) (d.nm), the polydispersity index (PDI) and the estimation of 
Molecular weight (Mode ± SD) are reported in table (4.2). In the graphs of proteins analysis, the 
distribution molecular mass (size nm) compared to the percentage of exclusion volume is 
reported.  
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  Hydrodynamic Radius Distribution Theoretical 
Mass (kDa) 
Protein Concentratio
n (g/l) 
Hydrodynamic 
radius (MODE ± 
SD) (nm) 
PDI (%) Est. MW (kDa) 
(Mode ± SD) 
 
FlgN 3.6 5.61 ±0.9 34 % 37.7 ± 6.3  21.1 
FliT 0.2 7.5 ± 3.7 41 % 74.9 ± 47.1  7.3 
FliN 0.5 58.77 ± 73.39 73 %   
HrcA 0.35 50.75 ± 19.17 39 %  29.7 
 3.5 164.2 ± 77.1 41 %    
Orf 6.1 13.54 ± 4.8 34 % 295 ± 110 43.8 
A  B  
C  D  
E  
Figure 4.6 - DLS spectra of purified 
recombinant FlgN (A), FliT (B), FliN (C), HrcA 
(D), ORF (E) 
 
Results and Discussion  
H. pylori colonizes more than half of world population, and severe and lethal diseases have been 
associated to its infection. Its ability to survive and to colonize the human gastric mucosa are still 
not fully understood. This study was focused on the pathogenic factors related to motility and on 
proteins involved in cellular stress response. Pathogenic proteins are possible new 
pharmaceutical targets, since when their activity is inhibited, the host infection is blocked. More 
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severe outcomes have been associated to more motile H. pylori strains. Hence, bacterial motility 
has been classified as one of the most important colonization determinants.   
H. pylori FliN 
H. pylori has evolved a complex system that, owing to its motility and chemotaxis, allows him to 
move to different micro-niches of the human gastric mucosa and prevent its discharge through 
peristalsis. Bacterial motility has been studied for more than 30 years, and all components of the 
flagellar substructure have been identified (Macnab RM, 2003). The flagellar switch mechanism 
is one of the most fascinating topics of bacterial motility. The C – ring complex of flagellar basal 
body is constituted by three proteins: FliG, FliM and FliN, each one present in many copies 
(Thomas DR, 2006). FliN has been observed to interact with type III secretion system 
components, facilitating the delivery of extracellular components (Gonzales-Pedrajo B, 2006). 
FliN plays a critical role in switching the movement direction. The binding of phosphorylated 
CheY mediates the signaling and promotes the clockwise rotation. Even if different structural 
studies and electron microscopic images of the flagellar basal body complex from Salmonella 
have been captured, the molecular structure of several proteins involved in this complex has not 
been determined yet. Recently, the crystal complex of Salmonella FliM with FliG C – terminal 
domain has been published (Paul K, 2011), but little is known about the molecular structure of 
flagellar C- ring component FliN of any species.  
H. pylori FliN was cloned and expressed in E. coli. After lysis, it resulted to accumulate in 
inclusion bodies. Denaturation of the lysate insoluble fraction has been performed with 
Guanidine 6 molar buffer. The unfolded protein was linked on a Ni affinity column and, after 
different steps with refolding buffer (Tris 20 mM pH 7.5, NaCl 100 mM), was eluted in 300 mM 
imidazole. With a Sigma PD-10 desalting column, the eluent used for affinity was removed. 
Purity and concentration of the protein has been measured with UV/Vis spectroscopy. It was 
possible to estimate that, in these conditions, around 2 g/l of recombinant protein was 
expressed and purified from 1 liter of E. coli culture. Recombinant FliN sequence was analyzed 
and the monomer resulted to weight 14,788.9 Da, with a theoretical isoelectric point of 5.5. 
Denaturant sodium dodecyl sulfate gel electrophoresis, stained with Comassie reagent, 
confirmed protein concentration, purity level and predicted apparent molecular weight (Figure 
4.4). The protein was concentrated to 10 g/l and different crystallization screens have been 
tested. Hard precipitate is present into the crystallization drop. The oligomerization state of the 
protein has been analyzed. Analytical gel filtration chromatography and DLS measurements 
revealed that recombinant FliN is polydisperse in solution (73%), suggesting that in these 
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conditions the protein is not suitable for crystallization. Different approaches need to be 
investigated to increase the monodispersity of H. pylori FliN in solution for structural purposes.      
 
Image 4.4 FliN SDS-PAGE 
purified protein. Purified 
recombinant FliN sample - LMW 
(25, 18.4, 14 kDa) 
 
        Substrate specific chaperones (FlgN - FliT) and Hook Associated Proteins (FlgL - FlgK - 
FliD) 
To prevent axial polymerization of flagellar components involved in an extracellular substructure 
as the hook junction or the filament cap, specific chaperones are necessary. After the formation 
of flagellar hook, coordinated by the two hook scaffolding proteins FliK and FlgD, proteins HAP1 
(FlgK and FlgL) and HAP2 (FliD) are exported through a flagellar central channel, large around 25 
- 30 Å (Ruiz T, 1993). A molecular mechanism controls the folding process and mediates the 
export of partially unfolded monomers, preventing cytosolic oligomerization (Namba and 
Vonderviszt, 1997). Type III secretion system components FlgN and FliT have been observed to 
play this specific role in the flagellar system. The goal of this study was the co-expression of 
HAPs with its specific chaperone for structural analysis. 
Helicobacter pylori G27 strain has been used as template to amplify the nucleotide sequence of 
FlgN, FliT, FlgK, FlgL, and FliD genes. The primers designed for HAPs contain a N-terminal strep–
tag and a restriction site. The primers designed for specific chaperones contained a nucleotide 
sequence for direct molecular cloning. The amplified DNA of each chaperone has been cloned in 
a plasmid vector in frame to His–tag in the C-terminal domain and the HAPs have been cloned in 
a storage vector, for a successive cloning step in an expression plasmid vector. This last step was 
unsuccessful and the HAPs interaction with their specific chaperones needs to be still 
investigated. Nevertheless, structural studies on H. pylori FlgN and FliT have been deeply 
investigated. The recombinant FlgN and FliT plasmids have been transformed and expressed in 
BL21 E. coli strain. Bacteria have been lysed with French press and clarified by centrifugation. 
FlgN was purified by the soluble fraction of the lysed, whilst the FliT pellet was treated with 
denaturant buffer and refolded during the affinity purification step (Oganesyan N, 2005). The 
soluble protein fractions have been analyzed with SDS-PAGE, confirming the predicted apparent 
molecular weight. The secondary structure of these proteins has been investigated with circular 
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dichroism. A peculiar spectrum for FliT was observed. Analysis with the CDNN 2.0 deconvolution 
software indicates a predominance of β-strand, a conformation significantly different from that 
of Salmonella enterica FliT (EA7M), characterized by a single α-helix (Imada K, 2010). Analytical 
gel filtration chromatography revealed that FlgN was eluted as a monomer, experimental data 
confirmed by dynamic light scattering measurements, where the protein presented a 
hydrodynamic radius of 5.6 (±0.9) nm and a polydispersity of 34 %. Instead, FliT presents 
different oligomerization states, observed in gel filtration analysis (Data not shown). The main 
oligomerization species, estimated by DLS, was of 7.5 (± 3.7) nm with a polydispersity of 41 %. 
Therefore, preliminary results promote FlgN for a more suitable crystallographic investigation, 
but even if the protein was concentrated to 10 - 30 - 60 g/l and different tests with crystallization 
screening were performed, unfortunately no protein crystals were obtained. The investigation of 
the molecular structure of H. pylori specific HAP chaperones have been studied in order to 
understand how secondary structure of little chaperone proteins could be influenced by the 
presence of its specific substrate. The missed goal to obtain crystals of the single chaperone 
protein and HAP-chaperone complex failed. This project presented anyway some preliminary 
results for further investigation of these housekeeping H. pylori flagellar proteins involved in 
bacterial motility.         
 
Hsps 
In order to survive in the gastric environment and establish chronic colonization of the human 
stomach, the bacterium H. pylori had evolved different pathogenic virulence factors, which also 
include heat shock proteins. The transcription of these proteins is regulated by three operons 
that encode the major cellular chaperone machineries that include hspR and hrcA genes. These 
two transcriptional repressors mediate the expression of these operons.  For crystallization 
purposes these proteins have been expressed and purified. In particular HspR and HrcA, both 
transcriptional factors, and HP1026, a protein of unknown function. These proteins have been 
expressed in E. coli and purified by IMAC affinity. To determine the level of protein purity and 
the apparent molecular weight, the purified samples have been checked in sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), stained in Comassie Brilliant Blue reagent 
(Figure 4.6 A). They are hardly soluble. In fact, the HspR concentration solubility limit is about 0.7 
g/l during sample concentration for crystallization trials. The protein precipitated giving rise to 
insoluble aggregates. A recent successful strategy to increase protein solubility and prevent 
protein aggregation was single nucleotide mutagenesis of Cys into neutral residue (Dian C, 
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2011). Following this result, HspR Cys in position 2 was mutated into a Tyr, using the site 
directed mutagenesis kit. The presence of a Tyr resulted to be conserved in other H. pylori 
strains, data confirmed by ClustalW sequence alignment (Data not shown). Unfortunately HspR 
solubility of the HspR mutant did not increase. PDP-blast HspR sequence alignment with the PDB 
sequence database revealed that E. coli CeuR (1Q05, Wang Y, 2007) presents the best sequence 
similarity with H. pylori, 33 %. The molecular structure of this protein has been solved by crystals 
incubated with 1 g/l of protein solution, suggesting a common solubility limit of this class of 
proteins. HrcA was insoluble and it was purified from the membranes resuspended in presence 
of detergents (NP40 0.1%). HrcA behavior was experimentally demonstrated by DLS 
measurements. Different concentrations of protein solution have been analyzed and it was 
observed that the hydrodynamic radius of particle aggregates increases when the protein 
solution is more concentrated. In fact, at 0.35 g/l the particle presents a 50.7 (± 19.2) nm radius 
and at 3.5 g/l 164.2 (± 77.1) nm with a polydispersity around 40 %. Detergent solubility screening 
has been performed (Figure 4.6 B) and the best detergent resulted to be NP-40 at 2.5% w/v. In 
this condition the protein was concentrated and crystallization tests have been performed. 
Finally Orf (HP1026) has been expressed in E. coli and resulted soluble after lysis and 
clarification. The protein was purified by Ni-IMAC affinity and then gel-filtered with a preparative 
Superdex 200 GL chromatographic column. Protein characterization by analytical gel filtration, 
dynamic light scattering and circular dichroism was performed. The secondary structure has 
been determined by dichroic spectra deconvolution: the protein presents a large content of α-
helices (35 %).  Analytical gel filtration analysis reveals a possible trimeric oligomerization state, 
even if DLS measurements predicted a hexameric homoligomeric state. Orf sequence similarity 
with the whole protein database has been performed with p-Blast , and a possible ATP binding 
domain has been identified. Therefore, the protein has been concentrated to 15 - 30 - 60 g/l and 
crystallization trials have been performed with the purified protein (Figure 4.6 C) and in 
presence of one equivalent ATPγS (SIGMA). No protein crystals have been obtained yet.  
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A  B  C  
Image 4.5 SDS – PAGE.  A) LMW(97, 66, 45, 30, 20 14 kDa) - HspR; B)  LMW (97, 66, 45, 30, 20 14 kDa) - HrcA; C) 
LMW (116, 66, 45, 30, 20, 18, 14 kDa) - Orf (HP1026) purified samples  
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Introduction 
 
SKI-1/S1P (Site 1 Protease / Subtilisin Kexin Isozyme 1) is a serine protease that belongs to the 
mammalian family of Proprotein Convertases (PCs) phylogenetically correlated to yeast kexin 
and bacterial subtilisin. Their function is to mediate the proteolysis of different substrates 
relevant for the life of the cell (Tourè BB, 2001). Alzheimer disease (Creemers J, 2001), 
tumorigenesis (Khatib A, 2002), and viral infections as HIV-1 (Muolard M, 1999) have been 
associated to PCs activity and so they are considered as possible pharmaceutical targets 
(Couture, F, 2001). Some of the proteases of the family, i.e. furin, PC5/6, PC7, and S1P, are 
ubiquitously expressed, whilst others are more tissue-specific. In order to be activated, this class 
of proteases requires an auto-proteolytic activation step (Fùgere M, 2005). The majority of PCs 
substrates have a highly selective cleavage site at pairs of basic residues: the minimal consensus 
sequence recognition of the substrate is R-X-X-R↓, where X could be any residues (Hosaka M, 
1991). On the contrary, a unique behavior was observed for S1P/SKI1 enzyme, which does not 
require a basic amino acid at the cleavage site. In fact, S1P cleavage site could be composed by 
single or pairs of basic residues, as Lys or Arg or hydrophobic residues as Leu, Phe, Val, or Met, 
generating a more complex motif R/K-(X)n-R/K↓, where X is any residues except Cys and n = 0, 2, 
4, or 6 residues (Seidah N, 1998). Therefore, S1P has been shown to have an unique substrate 
specificity, preferring cleavage after non-basic amino acids (Bodvard K, 2007).  
S1P is synthesized as an inactive precursor of 1052 amino acids in the endoplasmic reticulum 
(ER), and undergoes three sequential autocatalytic processing steps. In the first process, S1P 
cleaves the pro-domain at sites B’ (RKVF↓) and B (RKVFRSLK↓), then in Golgi it processes site C 
(KHQKLL↓), near the transmembrane domain (Elagoz A, 2002). The last cleavage produces a 
soluble S1P, whose biological role is still not well understood (Pullikotil P, 2007).     
S1P substrates are very important for cell homeostasis as well as for endocrine regulation. S1P 
knockout is lethal and liver-induced knockout produces mice with reduced cholesterol and fatty 
acid synthesis ability. One of the most important S1P substrates till now identified is SREBP 
(Sterol Regulatory Element Binding Protein), whose processing occurs in early Golgi apparatus 
(Brown M, 2000). S1P and S2P process SREBP playing a key role in lipid metabolism and 
cholesterol by regulating the feedback mechanism of cellular lipid homeostasis. Among 
identified S1P targets, pro-BDNF (brain derived neural factor) is probably delivered in the correct 
form at the secretory pathway (Seidah N, 1998).  The activation of the major cellular factor ATF-
6 involved in unfolded protein response is also mediated by S1P activity (Ye J, 2000). Finally, 
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related to cellular viral infection, the surface glycoprotein of a Lassa virus (Lenz O, 2001), 
lymphocytic choriomengitis (Beyer W, 2003) and Crimea Congo hemorrhagic fever virus (Vincent 
M, 2003) has been identified as S1P substrates.  
Kinetic and biochemical information of S1P properties are sparse and not always coherent. The 
most relevant controversy is related to human S1P as a serine Ca2+-dependent protease (Touré 
B, 1999), whilst hamster S1P does not require Ca2+ (Cheng D, 1999). Structural information of the 
pro-protein convertases family are confined to kexin progenitor, whilst the three dimensional 
structure of S1P is not known yet. Therefore, different functional domains of S1P have been 
produced and purified for crystallographic purposes. Moreover, the processing of an S1P mutant 
was studied with mass spectrometry to identify a possible alternative cleavage site in the 
regulatory domain.         
Materials and Methods 
Construct design, cloning and mutagenesis 
 
Figure 1.5 S1P synthetized constructs (cS1P, ProD_AB, ProD_AC, sS1P) compared to SKI-1/S1P protease domains.  
Table 5.1 S1P/SKI-1 analyzed constructs. 
 Amino 
acids 
Molecular 
weight 
Constructs Domain 
from residue –  
to residue 
S1P 
1052 117,7 kDa 
  
 
cS1P 
 
296 32,2 kDa WT 
S414A 
H249A 186 - 482 
ProD_AB 
 
124 14,2 kDa WT 
 
17 - 129 
ProD_AC 
189 21,3 kDa WT Mut C 
17 - 236 
sS1P or BTMD-S1P 
997 111,1 kDa WT Mut C 1 - 997 
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Different S1P domains have been synthesized to be adapted to the codon usage in E. coli (Life 
Technologies™). Optimized genes have been design for 2 protein domains: the catalytic (cS1P) 
and the pro regulatory domain (ProD_AC). They have been inserted into storage vectors (pMK 
and pMA). The prodomain corresponding to the fragment processed at the B site (ProD_AB) has 
been obtained from ProD_AC plasmid. cS1P starts from residue 186 to 482 and ProD from 
residue 17 to 186 of the S1P amino acids sequence. Nucleotide primers have been designed to 
amplify the construct present in the pMK-cS1P vector (forward: CAC CAT GCG TGC AAT TCC GCG 
T and reverse 3’-5’: CGC CTG CGG TTT ATA GCT ATT). Two constructs starting from pMA-
ProD_AC vector have been generated to study domain ProD. The first required (forward 5’-3’: 
CAC CAT GTA TCC GTA TGA TGT T and reverse 3’-5’: GCC ACC GGT TTC CGG CAG GCT) primers to 
be amplified and subcloned in an expression plasmid vector ProD_AC construct; the latter was 
for ProD_AB construct (forward 5’-3’ - GAA GGA GAT ATA CAT ATG AAA AAA CAT CTG  GGT GA 
and reverse 3’-5’ - GTG ATG GTG GTG ATG ATG TTG CGG TGT AAC ACG). Template DNA was 
amplified by PCR, using proofreading pfu DNA polymerase (Finnzymes). The amplified fragments 
were cloned into the pET101vector (Invitrogen) and pETite (Lucigen) in frame with a C-terminal 
His-tag, using a TOPO® Cloning kit to obtain pET101-cS1P, pET101-ProD_AC and pETite-ProD_AB 
plasmids. The appropriate insertion in the expression vector was confirmed by colony PCR and 
by sequencing with T7 forward and reverse primers.  
Double-point mutation of the pET101-cS1P was performed with the QuickChange® Site-Directed 
Mutagenesis Kit (Stratagene) using oligonucleotides to introduce the mutations. The following 
primers have been used to change from His residue to Asp and then into Ala: cS1P_H294D 
forward 5’- cS1PH249D: GAT GAT GGT CTG GGT GAT GGC ACC TTT GTT G and reverse 3’- 
cS1PH249D: CAA CAA AGG TGC CAT CAC CCA GAC CAT CAT C and cS1PD249A_fw: GAT GAT GGT 
CTG GGT GCT GGC ACC TTT GTT G and cS1PD249A_rev: CAA CAA AGG TGC CAG CAC CCA GAC 
CAT CAT C respectively.  The positive colonies have been verified by DNA sequencing. 
Another construct of S1P was design in order to understand the role of aoutoprocessing events 
during the maturation of the enzyme. sS1P (soluble S1P) or BTMD-S1P (Before Trans-Membrane 
Domain S1P) starts from residue 1 to 997 of the S1P sequence excluding the transmembrane 
and the C-tail domain producing a soluble form of S1P after the processing of the Signal peptide. 
sS1P was produced in two different forms, a native variant and a mutated form that presents a 
double mutation at the C cleavage site in order to block that processing event.  
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 Overexpression, purification and crystallization trials 
E. coli BL21(DE3) cells (Invitrogen) were transformed with the pET101-cS1P_H294A plasmid. 
Protein expression was induced by 0.5 mM IPTG (Sigma) in 2 liters of reach medium for 4h 
incubation at 28° C, supplemented with Ampicillin (100 µg/ml). Bacteria were collected and 
resuspended in a lysis buffer 30 mM HEPES, pH 7.5, 200 mM NaCl and NP-40 0.01% containing 
protease cocktail inhibitors: PMSF 0.2 mM, Complete Mini EDTA free cocktail (Roche) and 
specific inhibitors: CuSO4 1 mM, Zn Acetate 1mM and chloromethyl ketone 3µM. The suspension 
was disrupted by a One Shot Cell breakage system at 1.35psi (Constant System Ltd., UK). The 
lysate was clarified by centrifugation to remove cell debris at 18,000 g for 30 minutes and loaded 
into a column containing 1 ml of Ni2+ charged Chelating Sepharose™ (GE Healthcare, UK). After 
washing with 20mM imidazole buffer, the protein was eluted by a linear gradient of 300 mM 
imidazole. Positive fractions were collected and purified by gel filtration chromatography, using 
a Superdex 200™ 16/60 GL (GE Healthcare) equilibrated with 30 mM Na Citrate 20 mM pH 7.5, 
200 mM NaCl.  
Recombinant ProD_AC was overexpressed in transformed E. coli BL21(DE3) cells, grown in LB for 
4 hours at 28° C after induction with 0.5 mM IPTG. The bacteria were collected, suspended in 
lysis buffer (Na2HPO4 20 mM pH 7.5, NaCl 300 mM) supplemented by PMSF 0.2mM and NP-40 
0.01%, disrupted by a One Shot Cell breakage system at 1.35psi (Constant System Ltd., UK) and 
clarified by centrifugation (18,000 g for 30 minutes). Affinity purification was performed with 1 
ml Ni-IMAC column (GE-Healthcare) and gel filtration chromatography with Superdex 200 16/60 
(GE-Healthcare).  
ProD_AB was expressed in E. coli BL21(DE3) optimized strain (Lucigen), grown for 3 hours at 37° 
C after induction (0.5 mM IPTG). The collected bacteria were incubated in a denaturating buffer 
(Na2HPO4 20 mM pH 7.5, NaCl 150 mM, Guanidine 6 M) for 18 hours and then lysed by a One 
Shot Cell breakage system at 1.4 psi (Constant System Ltd., UK). The lysate was centrifuged 
(25000 g 30 minutes) and loaded in a 1 ml Ni2+ Sepharose column (GE Healthcare). The eluted 
fractions were subjected to different refolding trials (Table 5.2), without successful results.  
In order to understand the importance of the single SKI-1/S1P autoprocessing events and their 
role on the maturation and activity of the enzyme, we generated the C mutant, by replacing R183 
and R184  with E respectively. sS1P WT and Mutant C transfections have been performed in 
serum-free suspension cultures of HEK 293 cells at scales from 10 ml to 500 ml in agitated non-
instrumented cultivation systems. Transfection vector derive from a pIRES-S1P-BTMD construct 
modified to add a His6 tag to the C terminus, pIR-S1P-BTMD(6×His). The recombinant pro-
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protein includes its native signal sequence for the appropriate targeting and secretion in the cell 
culture medium, that is collected for further purification steps, while the cells pellet is discarded. 
The protein has been isolated from two harvests of cell culture supernatant (3rd and 7th day). 
These constructs were overexpressed in HEK293 cells which lacks SKI-1/S1P and their auto-
processing profile compared to SKI-1/S1P WT (positive ctrl) and SKI-1/S1P H249A (catalytically 
dead, negative ctrl). Surprisingly, replacement of C site R183, R184 with E did not impair 
maturation. The protein was isolated by IMAC-Co chromatography (Co-TALON resin, GE 
Healthcare) and eluted with 20 mM Tris-HCl, pH 7.5 containing 150 mM NaCl, 300 mM 
Imidazole.  
Protein quantification was performed by UV/Vis spectroscopy (280nm, Cary 50 Bio UV-Visible 
spectrophotometer, Varian Inc.) using theoretical absorption coefficient combined to 15% 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE). The resolved gels were 
stained with 0.25% Coomassie Brilliant Blue R250 reagents. 
Recombinant protein samples have been concentrated to 10 g/l and used for crystallization tests 
partially automated using an Oryx 8 crystallization robot (Douglas Instruments), but no protein 
crystals have been obtained so far. 
 Circular dichroism 
Recombinant ProD_AC has been analyzed by circular dichoism using a JASCO J-715 
Spectropolarimeter at 298K.  Molar ellipticity measurements were performed using a 0.05 cm 
path quartz cell in Na2HPO4 / NaCl, pH 7.5 buffer, in the wavelength interval 190-260 nm. A 
solution containing the buffer was used as blank. 
 
Figure 5.2. Circular dichroism of soluble fraction of recombinant ProD_AC 
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S1P RP-HPLC and MS analysis 
Reduction of S1P (WT and Mut C) disulfide bridges was obtained with Tris (2-carboxyethyl) 
phosphine (TCEP), using a molar ratio of 1:10 (Cys:TCEP) and S-carboxymethylation by using 
iodoacetamide (IAA) in molar ratio of 1:10 (Cys:IAA). The sample was dissolved in 20 mM Tris-
HCl pH 8.5 containing 6 M Guanidine-HCl and treated with TCEP for 30 min at 37°C; after that 
IAA was added and the sample kept in the dark for 30 min at room temperature. The sample was 
then subjected to RP-HPLC analysis. 
RP-HPLC analysis was performed using a C4 column (150 x 4.6 mm), eluted by a linear gradient 
(10-70%) in aqueous trifluoroacetic acid/CH3CN solvent, monitoring at 226 nm at a flow rate of 
0.6 ml/min. The sample was denatured in 6 M Guanidine-HCl before loading in RP-HPLC,. The 
eluted fractions corresponding to the major HPLC peaks were dried out in a speed-vac 
concentrator, dissolved in 50% acetonitrile, 0.1% formic acid and directly injected in the ESI 
source. Mass measurements were performed with a quadrupole-TOF spectrometer (Waters, 
Manchester, UK) (capillary voltage: 2800–3000 V; cone voltage: 45 V; scan time: 1 s; interscan: 
0.1 s). Spectra were analyzed using MASSLYNX software (Micromass, Wynthenshow, UK). 
 
Results and Discussion  
S1P is a 118 kDa multi-domain protein; therefore, our approach has been focused on two main 
regions of S1P: the "Pro domain", involved in the inhibition of S1P catalytic activity, and the so 
called "catalytic domain", which includes the residues responsible for the cleavage reaction 
itself. 
Hence, the sequences corresponding to the before mentioned domains were synthesized as 
optimized genes for the expression in E. coli and sub-cloned in expression plasmids in order to 
obtain C-term His-tagged fusion proteins. The construct corresponding to the catalytic domain 
(cS1P) was produced both as wild type and in a mutated form (His249Ala) and (S414A) to abolish 
its proteolytic activity and increase its stability. The corresponding proteins were expressed and 
extracted by E. coli cells sonication in phosphate buffer, supplemented with detergent and 
protease inhibitors and the resulting extract clarified by centrifugation. The supernatant was 
loaded in a His-Trap column and eluted by imidazole gradient. The eluted fractions were pooled 
and further purified by size exclusion chromatography. The resulting samples were analyzed by 
SDS-PAGE electrophoresis and those containing the purest and most homogeneous cS1P protein 
91 
 
were concentrated to 10mg/ml for crystallization trials. Sparse matrix crystallization screenings 
(isothermal vapor diffusion setup) were performed by a semi-automated robot (Oryx8), but no 
protein crystals have been obtained yet. 
Two different constructs of the regulatory ProDomain have been sub-cloned, according to the 
physiological multi-sites processing events it undergoes upon S1P folding, trafficking and 
activation: ProD_BB' and ProD_AB, corresponding to 22 and 14 kDa domains, respectively. 
While ProD_BB' was soluble but quite unstable if produced in E. coli cells, ProD_AB was highly 
expressed but insoluble and enriched in the inclusion bodies. Therefore, ProD_AB has been 
expressed in E. coli, denatured, isolated by His-tag affinity chromatography and submitted to 
multiple refolding conditions in order to identify the most promising ones. Unfortunately, the 
refolding attempts till now tried did not allow to isolate any soluble refolded fractions of such 
domain. Other purification strategies, as well as different expression systems, need to be 
explored to overcome the encountered difficulties.      
 1 2 3 4 5 6 7 8 
 
Arginina 400 mM 400 mM 400 mM 400 mM 400 mM    
MgCl2 2 mM 2 mM 2 mM 2 mM 2 mM    
KCl 2 mM 5 mM 5 mM 5 mM 5 mM    
MES  50 mM 50 mM  50 mM     
PEG 3350 0,05%        
GSSG  0,1 mM 100 mM 100 mM 100 mM 100 mM    
GSH  1 mM 1 mM 1 mM 1 mM 1 mM    
CaCl2  2 mM 2 mM 2 mM 2 mM   5 mM 
Sucrose  300 mM 300 mM 300 mM 300 mM    
NaCl  240 mM 240 mM 10 mM 10 mM 300 mM 300 mM 100 mM 
TRIS    50 mM  50 mM    
NaH2PO4      50 mM 50 mM 50 mM 
NP 40      0, 01 % 0,01 % 0, 05 % 
DTT      1 mM  2 mM 5 mM 
EDTA        5 mM 
pH 6.0 6.0 8.0 6.0 8.0 7.5 7,5 6.5 
Table 5.2. ProD tested refolding conditions. Figure 5.3 SDS PAGE LMW (97, 66, 45, 30, 20, 14 kDa); Dialyzed 
ProD_AB (condition n.8); ProD_AB purified from inclusion bodies. 
 
The double substitution of residues at the cleavage site C (sS1P_mut_C) has been studied on a 
soluble construct of S1P and compared with wild type protease (sS1P_WT). Auto-processing 
fragments of regulatory ProD domain of both recombinant proteins, expressed and purified from 
the supernatant of a mammalian HEK293 cells culture, were detected and separated by RP-HPLC 
(Figure 5.6). Eluted fractions have been analyzed by MALDI-TOF spectrometer and the 
corresponding profiles compared and further analyzed (Table 5.3). 
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A 
 
B 
 
Image 5.4. SDS-PAGE purified cS1P and ProD_AB 
recombinant constructs of human S1P protease A) 
cS1P, LMW (97, 66, 45, 30 kDa) B) ProD_AB, LMW 
(97, 66, 45, 30, 20, 14 kDa) 
 
 
Mass Spectrometry analysis 
Recently, furin, a member of the PCs family, was also found to have additional processing sites in 
the prodomain region (Gawlik, 2009). Similarly, it is conceivable that the SKI-1/S1P C is the result 
of a double cleavage event (C’/C) and that, likewise B’/B, simultaneous blockage of both C and C’ 
processing are required to trap SKI-1/S1P mainly in the intermediate immature form.  
To identify the exact C’ cleavage site, a MALDI-TOF-MS analysis was performed. A soluble 
(truncated before the transmembrane domain) SKI-1/S1P C mutant-6His was generated (SKI-
1/S1P C-BTMD), produced in HEK293 and purified by IMAC chromatography (Fig. 5.5). Purified 
wt SKI-1/S1P-BTMD was likewise analyzed in parallel. Using standard MALDI-TOF-MS conditions, 
both prodomain fragments at site B and B’ were found attached to the mature form. Further 
prodomain fragments of molecular weight higher than the B’/B became visible only upon 
carboxymethylation, suggesting the existence of a covalent bond between the enzyme and its 
AC prodomain. In the context of the mutant, multiple C’ cleavages were identified, all within the 
hypothesized region at RRASLSLG170, WHATGRHS181, and WHATGRHSSEE184 motifs. The 
unusual sequences at the cleavage sites do not fit any specific protease consensus motif, 
although an auto-processing event cannot be ruled out. Accordingly, shedding occurs at QKLL953 
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which does not follow the SKI-1/S1P RX(hydrophobic)X motif (Toure et al, 2000). With the 
exception of WHATGRHSSEE184, which is an obvious consequence of the RR184 replacement by 
EE, the other fragments found also in the WT enzyme are supportive of a physiological complex 
processing of SKI-1/S1P prodomain.  
We propose that SKI-1/S1P activation occurs through sequential and/or alternative excisions at 
B’/B and at C’/C without the physical release of the prodomain from the rest of the molecule, 
thus leading to a heterogeneous population. As a consequence, inhibition of one of the complex 
auto-processing events alters the relative composition of such population. 
  
Image 5.5. SDS-PAGE purified SKI-1/S1P-BTMD (MUTANT C and WT) constructs. 
S1P/SKI1 Mut C 
 
Theoretical 
MW (Da) 
Experimental 
MW (Da) 
Modi
ficati
on 
(Da) 
Retenti
on 
time 
Protein Domain Sequence 
13211,8 13211,61 ± 0,46  23,8 6    120 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTAKARNSFIS
SALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKR
VTPQRKVFRSLK 
5945,86 5945,18 ± 06  19,2 70  120 IIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQRKVFRSLK 
4360,08 4361,31 ± 08  19,7 81  117 PSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQRKVFR 
13221,08 13325,15 ± 0,17 CM 29,5 6    120 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTAKARNSFIS
SALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKR
VTPQRKVFRSLK 
14064 14122,67 ± 9,74 CM 30,9 46  167 YFTAKARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGL
LTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSSRPLR
RASLSLGSGFWHATGRHSSEE 
13719,4 13781,6 ± 7,6 CM 30,9 46  164 YFTAKARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGL
LTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSSRPLR
RASLSLGSGFWHATGRHS 
8562,69 8563,12 ± 0,43  28,1 41  115 VAFNGYFTAKARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEK
QKAGLLTLEDHPNIKRVTPQRKV 
6935 6992.77 ± 0.33 CM 20,2 94  153 KAGLLTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSS
RPLRRASLSLG 
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S1P/SKI1WT 
 
Theoretical 
MW (Da) 
Experimental 
MW (Da) 
Modifi
cation 
(Da) 
Retention 
Time 
Protein Domain Sequence 
13211.0847 13209.56 ± 0.3  23,6 6  120 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTA
KARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQ
KAGLLTLEDHPNIKRVTPQRKVFRSLK 
13082.9106 13081.39 ± 0.55  23,6 6  119 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTA
KARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQ
KAGLLTLEDHPNIKRVTPQRKVFRSL 
9827.0482 9827.29 ± 1.19  25,5 6  91 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTA
KARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKE 
5945.8 5930,07 ± 0,19 cycling 18,9 70  120 IIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQR
KVFRSLK 
5945.8 5946,24 ± 0,55  18,9 70  120 IIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQR
KVFRSLK 
10733.0617 10734.74 ± 1.85  25,5 72  164 PRNNPSSDYPSDFEVIQIKEKQKAGLLTLEDHPNIKRVTPQRK
VFRSLKYAESDPTVPCNETRWSQKWQSSRPLRRASLSLGSGF
WHATGRHS 
13211.0847 10734.74 ± 1.85 CM 25,5 72  164 DRLEKKSFEKAPCPGCSHLTLKVEFSSTVVEYEYIVAFNGYFTA
KARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQ
KAGLLTLEDHPNIKRVTPQRKVFRSLK 
 13269.03 ± 0.28 CM 1 
CM 2 
23,5 6    120 KAGLLTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNETRW
SQKWQSSRPLRRASLSL 
6934.9547 6936.64 ± 1.34  19 94  153 TAKARNSFISSALKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKE
KQKAGLLTLEDHPNIKRVTPQRKVFRSLKYAESDPTVPCNET
RWSQ 
10360.6662 10361.62 ± 0.33  32 48  137 LKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLED
HPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSSR
PLRRASLSLGSGFWHATGRHSSRR 
12574.1659 12590.27 ± 0.47 OX 32 60  167 LKSSEVDNWRIIPRNNPSSDYPSDFEVIQIKEKQKAGLLTLED
HPNIKRVTPQRKVFRSLKYAESDPTVPCNETRWSQKWQSSR
PLRRASLSLGSGFWHATGRHSSRR 
Table 5.3. MALDI-TOF-MS analysis. SKI-1/S1P-BTMD (MUTANT C and WT) prodomain autoprocessing measured 
molecular masses.  
 
 
Figure 5.6  HPLC Chromatogram. ProD processing of  SKI-1/S1P-BTMD (MUTANT C 
and WT) constructs. 
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